<SEC-DOCUMENT>0000721371-22-000049.txt : 20220722
<SEC-HEADER>0000721371-22-000049.hdr.sgml : 20220722
<ACCEPTANCE-DATETIME>20220722163509
ACCESSION NUMBER:		0000721371-22-000049
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20220718
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220722
DATE AS OF CHANGE:		20220722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDINAL HEALTH INC
		CENTRAL INDEX KEY:			0000721371
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				310958666
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11373
		FILM NUMBER:		221100318

	BUSINESS ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147573033

	MAIL ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDINAL DISTRIBUTION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cah-20220718.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:2eb8944f-de1f-415b-8bf2-41062c286f20,g:3e966e92-320a-412a-b21b-0469b6ff5c6d,d:4526add1f1814fd59a05327824107ddf--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cah-20220718</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl80L2ZyYWc6Y2JjNGIyNTQ1Y2VkNDNkZWJlM2YwNDdhYjI4MjdmNjQvdGFibGU6MzkwMjk1YmQ5YTQyNGEyOGFlMWQ5NzY3NzJlNjU5YTYvdGFibGVyYW5nZTozOTAyOTViZDlhNDI0YTI4YWUxZDk3Njc3MmU2NTlhNl8xLTEtMS0xLTE2NDc1Mw_724e7339-9a8c-4fa1-b8b7-470f1f6db7a3">0000721371</ix:nonNumeric><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl80L2ZyYWc6Y2JjNGIyNTQ1Y2VkNDNkZWJlM2YwNDdhYjI4MjdmNjQvdGFibGU6MzkwMjk1YmQ5YTQyNGEyOGFlMWQ5NzY3NzJlNjU5YTYvdGFibGVyYW5nZTozOTAyOTViZDlhNDI0YTI4YWUxZDk3Njc3MmU2NTlhNl8yLTEtMS0xLTE2NDc1Mw_2de731c4-51a9-4dbf-9698-f8d56a9dbac1">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cah-20220718.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-02</xbrli:startDate><xbrli:endDate>2021-04-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4526add1f1814fd59a05327824107ddf_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl83MDE_6f934b83-ccd9-40ab-a164-7511b31aea5f">8-K</ix:nonNumeric> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl8yMjQ_2f5650a3-1156-4fce-aecc-977500643713">July 18, 2022</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTQ_1edd9a8f-6653-4f35-a2af-7d197331a393">Cardinal Health, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.751%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6N2Y5YjgxZjVjNjhhNDA4YWFlNTkxNDQxZDA5NWUwYzkvdGFibGVyYW5nZTo3ZjliODFmNWM2OGE0MDhhYWU1OTE0NDFkMDk1ZTBjOV8xLTAtMS0xLTE2NDc1Mw_87a3fcaf-91c8-4b48-840b-1be48262801b">Ohio</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6N2Y5YjgxZjVjNjhhNDA4YWFlNTkxNDQxZDA5NWUwYzkvdGFibGVyYW5nZTo3ZjliODFmNWM2OGE0MDhhYWU1OTE0NDFkMDk1ZTBjOV8xLTItMS0xLTE2NDc1Mw_7aa18916-0cb7-450a-bc21-2fe22671c987">1-11373</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6N2Y5YjgxZjVjNjhhNDA4YWFlNTkxNDQxZDA5NWUwYzkvdGFibGVyYW5nZTo3ZjliODFmNWM2OGE0MDhhYWU1OTE0NDFkMDk1ZTBjOV8xLTQtMS0xLTE2NDc1Mw_87c75855-8ca3-4a02-92e4-6dfc380e2a48">31-0958666</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTU_59b1c6a3-166e-4085-9eee-20a0e07fcbca">7000 Cardinal Place</ix:nonNumeric>, <ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTY_34624e36-b182-4d31-84a2-d95b08e15b5d">Dublin</ix:nonNumeric>, <ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTc_0f25bfb1-3ffd-4657-93f8-0efe37cb3300">Ohio</ix:nonNumeric> <ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTg_1aa4c4a2-b94c-4f2c-b825-2a01d1633846">43017</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTk_c12ccaac-aa22-4067-8066-dfda601b9a53">614</ix:nonNumeric>) <ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl83MDA_374e0738-74d0-45d9-abe6-a0ef9af9f1b3">757-5000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6ZThjMzNhMGQ5NjQxNDRjYzk5NjM1MTMyZmNiNzdjNDcvdGFibGVyYW5nZTplOGMzM2EwZDk2NDE0NGNjOTk2MzUxMzJmY2I3N2M0N18wLTAtMS0xLTE2NDc1Mw_8dc7c697-e306-4f8c-85ba-b20a9040995c">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NTdmOTFhMzVhMjk1NDBjMzk3YzAxMjIwMTQyMWRkMWUvdGFibGVyYW5nZTo1N2Y5MWEzNWEyOTU0MGMzOTdjMDEyMjAxNDIxZGQxZV8wLTAtMS0xLTE2NDc1Mw_d817823a-10d6-4640-9858-844acd8129d4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NTY3ZWJlMjQzYmJlNDM3MjgwM2UwZGRlNDAyYzkxMDkvdGFibGVyYW5nZTo1NjdlYmUyNDNiYmU0MzcyODAzZTBkZGU0MDJjOTEwOV8wLTAtMS0xLTE2NDc1Mw_90499db8-c8a7-4f61-b04e-a4e53cfdd59c">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6ZGI2MmY3ZjFkNzQzNDExNmFhZWQ4ODU3Y2Y1MjQyY2YvdGFibGVyYW5nZTpkYjYyZjdmMWQ3NDM0MTE2YWFlZDg4NTdjZjUyNDJjZl8wLTAtMS0xLTE2NDc1Mw_d599e7b3-cc4d-4d56-a7c8-1a0736541114">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NzdlMDlhODVmNGZhNDUyMDgwMjZhNTYzMGU3YzZlNTYvdGFibGVyYW5nZTo3N2UwOWE4NWY0ZmE0NTIwODAyNmE1NjMwZTdjNmU1Nl8yLTAtMS0xLTE2NDc1Mw_eb1747b4-741b-41ec-a65a-0d08a2e9ddb8">Common shares (without par value)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NzdlMDlhODVmNGZhNDUyMDgwMjZhNTYzMGU3YzZlNTYvdGFibGVyYW5nZTo3N2UwOWE4NWY0ZmE0NTIwODAyNmE1NjMwZTdjNmU1Nl8yLTEtMS0xLTE2NDc1Mw_e0a74164-2d9d-4b14-8e34-6823ebc16960">CAH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NzdlMDlhODVmNGZhNDUyMDgwMjZhNTYzMGU3YzZlNTYvdGFibGVyYW5nZTo3N2UwOWE4NWY0ZmE0NTIwODAyNmE1NjMwZTdjNmU1Nl8yLTItMS0xLTE2NDc1Mw_664821a1-f5d5-4783-87d4-b08f0252eab6">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:92.301%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). <br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NmM2NjRjZDU5ZGQ5NDllMmE3MzI0ZThiOWM1OTQyZjgvdGFibGVyYW5nZTo2YzY2NGNkNTlkZDk0OWUyYTczMjRlOGI5YzU5NDJmOF8xLTEtMS0xLTE2NDc1Mw_cfef0eef-0c2c-46ea-8826-dd9fc457a04e">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></div><div><span><br/></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4526add1f1814fd59a05327824107ddf_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 8.01. Other Events. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2019, Melissa Cohen, a purported shareholder of Cardinal Health, Inc. (the "Company"), filed an action on behalf of the Company in the U.S. District Court for the Southern District of Ohio against certain current and former members of the Company's Board of Directors alleging that the defendants breached their fiduciary duties by failing to effectively monitor the Company's distribution of controlled substances and approving certain payments of executive compensation. In December 2019 and January 2020, similar complaints were filed in the U.S. District Court for the Southern District of Ohio by purported shareholders, Stanley M. Malone and Michael Splaine, respectively. In January 2020, the court consolidated these cases under the caption </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In re Cardinal Health, Inc. Derivative Litigation </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(the "Derivative Action"). In February 2021, the court dismissed the claim with respect to executive compensation but declined to dismiss the failure to monitor claim. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2021, the parties reached an agreement in principle to resolve the Derivative Action ("Settlement") and in July 2022, the court granted preliminary approval of the Settlement. Subject to final approval by the court, as part of the Settlement, the Company's director and officer's liability insurance carriers, on behalf of the defendants, will pay the Company $124 million, less any attorneys' fees and expenses awarded by the court to plaintiffs' counsel. The Settlement does not include any admission of liability. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company today provided notice to its stockholders of the Settlement in the form of a press release as well as this Current Report on Form 8-K, as required by the terms of the Settlement. The terms and conditions of the Settlement are set forth in the Stipulation and Agreement of Compromise, Settlement, and Release (&#8220;Stipulation&#8221;) and the Notice to Cardinal Health, Inc. Stockholders of Proposed Settlement of Stockholder Derivative Action, Settlement Hearing, and Right to Appear (&#8220;Notice&#8221;). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Copies of the Stipulation and Notice are attached hereto as Exhibits 99.1 and 99.2 and are incorporated by reference herein. A copy of the news release issued by the Company is attached hereto as Exhibit 99.3. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01 Financial Statements and Exhibits </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">              </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) Exhibits </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">99.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit991-8xk.htm">Stipulation and Agreement of Compromise, Settlement, and Release</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">99.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit992-8xk.htm">Notice to Cardinal Health, Inc. Stockholders of Proposed Settlement of Stockholder Derivative Action, Settlement Hearing, and Right to Appear</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">99.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit993-8xk.htm">News release issued by Cardinal Health, Inc. on July 22, 2022</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i4526add1f1814fd59a05327824107ddf_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Signatures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardinal Health, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 22, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;JESSICA L. MAYER</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jessica L. Mayer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Legal and Compliance Officer</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991-8xk.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i0678701d9929485294e1ecb570c6a70a_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">UNITED STATES DISTRICT COURT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">FOR THE SOUTHERN DISTRICT OF OHIO</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">EASTERN DIVISION</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.783%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="padding-left:36pt;text-indent:-5.25pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">IN RE CARDINAL HEALTH, INC. </font></div><div style="padding-left:36pt;text-indent:-5.25pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">DERIVATIVE LITIGATION</font></div><div><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br></font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Case No. 2&#58;19-cv-2491<br></font><font style="font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br></font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Judge Sarah D. Morrison<br></font><font style="font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br></font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Magistrate Judge Elizabeth A. Preston Deavers</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">STIPULATION AND AGREEMENT OF </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">COMPROMISE, SETTLEMENT, AND RELEASE</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">This Stipulation and Agreement of Compromise, Settlement, and Release (the &#8220;Stipulation&#8221;) is entered into this 25th day of Mayl, 2022, by and among&#58; (i) co-lead plaintiffs in the above-captioned stockholder derivative action Melissa Cohen, Stanley M. Malone, and Michael Splaine (collectively, &#8220;Plaintiffs&#8221;)&#59; (ii) individual defendants David J. Anderson, Colleen F. Arnold, George S. Barrett, Carrie S. Cox, Calvin Darden, Bruce L. Downey, Patricia A. Hemingway Hall, Akhil Johri, Clayton M. Jones, Michael C. Kaufmann, Gregory B. Kenny, Nancy Killefer, David P. King, and J. Michael Losh (collectively, &#8220;Individual Defendants&#8221;)&#59; and (iii) nominal defendant Cardinal Health, Inc. (&#8220;Cardinal Health&#8221; or the &#8220;Company,&#8221; and, together with the Individual Defendants, &#8220;Defendants&#8221;), constituting the parties (the &#8220;Parties&#8221; and, individually, a &#8220;Party&#8221;) in the above-captioned action (the &#8220;Action&#8221;), by and through their respective undersigned counsel.  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">This Stipulation is intended to fully, finally, and forever compromise, resolve, discharge, release, and settle the Released Claims (defined below) and dismiss the Action with prejudice, upon the terms and subject to the conditions set forth herein.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">A.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%;padding-left:10.26pt;text-decoration:underline">Opioid-Related Litigation and Settlements</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">in October 2008, Cardinal Health entered into a settlement agreement with the U.S. Department of Justice, Drug Enforcement Administration (&#8220;DEA&#8221;) (the &#8220;2008 Settlement&#8221;), to settle administrative claims relating to the Company&#8217;s distribution of controlled substances&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">in connection with the 2008 Settlement, Cardinal Health agreed to, among other things, pay $34 million in settlement of claims or potential claims for civil penalties and maintain a compliance program designed to detect and prevent diversion of controlled substances as required under the Controlled Substances Act and applicable DEA regulations&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">in May 2012, Cardinal Health entered into a settlement with the DEA (the &#8220;2012 Settlement&#8221;) to resolve a DEA order initiating administrative proceedings to revoke the registration of a Cardinal Health distribution center in Lakeland, Florida (the &#8220;2012 Lakeland Order&#8221;)&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> in connection with the 2012 Settlement, Cardinal Health did not then agree to pay a fine, but the government reserved its right to seek civil fines based on the conduct alleged in the 2012 Lakeland Order&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">in December 2016, Cardinal Health settled the government&#8217;s reserved claims for civil fines in connection with the 2012 Settlement and agreed to pay the United States $34 million&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">in December 2016, Kinray, LLC, a New York-based subsidiary of Cardinal Health, agreed to pay $10 million to settle a suit by the United States alleging that Kinray had failed to report suspicious orders placed by New York area pharmacies between January 1, 2011 and May 14, 2012&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">on December 12, 2017, the U.S. Judicial Panel on Multi-District Litigation centralized and transferred pending federal opioid-related cases brought by state and local governments against Cardinal Health, McKesson Corporation (&#8220;McKesson&#8221;), AmerisourceBergen Corporation (&#8220;AmerisourceBergen&#8221;), and certain pharmaceutical and pharmacy companies, to Judge Dan Polster in the United States District Court for the Northern District of Ohio (the &#8220;MDL&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">in December 2019, Cardinal Health entered into a settlement agreement to resolve opioid-related claims by two Ohio counties, Summit and Cuyahoga&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">in July 2021, a bench trial involving certain of the cases in the MDL concluded in West Virginia, and the parties in that suit are awaiting a verdict&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">on July 21, 2021, Cardinal Health announced that it, McKesson, and AmerisourceBergen, had negotiated a proposed settlement agreement and settlement process that, if all conditions were satisfied, would result in the settlement of the vast majority of opioid lawsuits filed by state and local government entities (the &#8220;2021 Agreement&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> the 2021 Agreement was binding as of February 25, 2022 and effective as of April 2, 2022, and includes injunctive relief terms governing the settling distributors&#8217; controlled substance anti-diversion programs (the &#8220;Injunctive Relief Terms&#8221;), a copy of which is attached as </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">Exhibit A</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">, that have been or will be implemented on or before July 1, 2022&#59;  </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">B.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%;padding-left:10.26pt;text-decoration:underline">This Action</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">, prior to the filing of the Consolidated Amended Complaint in the Action (the &#8220;Amended Complaint&#8221;) (ECF No. 35, PAGEID # 1715-1800), Plaintiffs obtained books and records from Cardinal Health pursuant to Section 1701.37 of the Ohio Revised Code&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">between June 14, 2019 and January 13, 2020, Plaintiffs filed three separate derivative actions (the &#8220;Individual Actions&#8221;) in this Court&#58;  (1) </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">Melissa Cohen v. Arnold, et al.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">, Case No. 2&#58;19-cv-2491&#59; (2) </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">Stanley M. Malone v. Anderson, et al.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">, Case No. 2&#58;19-cv-5442&#59; and (3) </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">Michael Splaine v. Anderson, et al.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">, Case No. 2&#58;20-cv-203&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">on January 28, 2020, this Court entered an order consolidating the Individual Actions for all purposes into the Action, under the caption </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">In re Cardinal Health, Inc. Derivative Litigation</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">, Case No. 2&#58;19-cv-2491&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">on February 11, 2020, the Court appointed Gardy &#38; Notis, LLP and Kessler Topaz Meltzer &#38; Check, LLP as co-lead counsel for Plaintiffs (&#8220;Co-Lead Counsel&#8221;), Isaac Wiles Burkholder &#38; Teetor, LLC and Strauss Troy Co., LPA as co-liaison counsel for Plaintiffs, and Mark Troutman, Esq. as trial counsel for Plaintiffs in the Action, and on February 6, 2021, Troutman joined The Gibbs Law Group, LLP and remained as trial counsel for Plaintiffs in the Action&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">on March 12, 2020, Plaintiffs filed the Amended Complaint&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">on June 19, 2020, Defendants filed a motion to dismiss the Amended Complaint (the &#8220;Motion to Dismiss&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">the Parties fully briefed the Motion to Dismiss, and, on January 21, 2021, the Court held a hearing on the Motion to Dismiss&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">on February 8, 2021, the Court issued an order granting in part and denying in part the Motion to Dismiss (ECF No. 58, PAGEID # 2218-2263)&#58;  (i) dismissing Count II of the Amended Complaint alleging waste of corporate assets, and (ii) sustaining Count I of the Amended Complaint alleging that the Individual Defendants breached their fiduciary duties&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">on March 25, 2021, United States Magistrate Judge Elizabeth A. Preston Deavers entered a Preliminary Pretrial Order (ECF No. 66, PAGEID # 2284-86), which, among other things, set certain deadlines for fact and expert discovery and other proceedings&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">on March 26, 2021, Plaintiffs propounded their First Request for Production of Documents, to which the Individual Defendants and Cardinal Health each served responses and objections on June 10, 2021&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">on April 7, 2021, Defendants each filed answers to the Amended Complaint and asserted various defenses with respect to Plaintiffs&#8217; claims, and the Individual Defendants further denied that any fiduciary breach took place&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">between April 30, 2021 and December 1, 2021, Cardinal Health produced to Plaintiffs more than 15 million pages of documents&#59;  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> on</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">October 28, 2021, Plaintiffs propounded their First Set of Interrogatories on Cardinal Health, to which Cardinal Health served responses and objections on December 8, 2021&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> the Parties engaged in numerous meet-and-confer sessions regarding various discovery matters and also began a discussion regarding a potential resolution of the Action&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">C.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%;padding-left:9.81pt;text-decoration:underline">The Settlement</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> on December 9, 2021, counsel for the Parties and representatives of Defendants&#8217; directors and officers liability insurers (&#8220;D&#38;O Insurers&#8221;), participated in a mediation session with the Hon. Daniel Weinstein (Ret.) and Jed D. Melnick, during which the Parties agreed in principle to settle the Action in return for a cash payment of one hundred twenty-four million dollars ($124,000,000), to be paid by the D&#38;O Insurers (the &#8220;Settlement Amount&#8221;) to the Company&#59;  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">after the substantive terms of the Settlement were agreed to, the Parties separately negotiated in good faith as to an appropriate Fee and Expense Award (defined below), and Cardinal Health has agreed, subject to approval of the Court, that Plaintiffs&#8217; Counsel (defined below) are entitled to a fee and expense award of 25% of the Settlement Amount for their role in prosecuting and settling the Action&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">this Stipulation (together with the exhibits hereto) reflects the final and binding agreement by and among the Parties&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">Plaintiffs continue to believe that their claims have merit but, based upon Plaintiffs&#8217; and Co-Lead Counsel&#8217;s investigation and prosecution of the Action, Plaintiffs and Co-Lead Counsel have concluded that the terms and conditions of this Stipulation are fair, reasonable, and adequate to the Company and its stockholders&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">Plaintiffs have agreed to settle and release the claims asserted in the Action pursuant to the terms and provisions of this Stipulation, after considering (i) the substantial financial benefit under the Settlement&#59; (ii) the comprehensive Injunctive Relief Terms already contemplated by the 2021 Agreement&#59; (iii) the uncertain outcome, inherent delays, and significant risks of continued litigation&#59; and (iv) the desirability of permitting the Settlement to be consummated as provided by the terms of this Stipulation&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">each of the Individual Defendants have denied, and continue to deny, that he or she committed, attempted to commit, or aided and abetted in the commission of, any breaches of fiduciary duty owed to Cardinal Health, or any violation of law or wrongdoing whatsoever, and expressly maintains that, at all relevant times, he or she acted in good faith and in a manner that he or she reasonably believed to be in the best interests of Cardinal Health and its stockholders&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> each of the Individual Defendants deny the allegations made by Plaintiffs in the Action and deny that Plaintiffs, Cardinal Health, or its stockholders suffered any damage or were harmed as a result of any act, omission, or conduct by the Individual Defendants as alleged in the Action&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">Cardinal Health believes that the Settlement is in the best interest of the Company, its stockholders, and its employees&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> Defendants are entering into this Settlement for the benefit of Cardinal Health to eliminate the uncertain outcome, distraction, disruption, burden, and expense inherent in further litigation&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">the Parties agree that this Stipulation (including the exhibits hereto) shall in no event be construed as, or deemed to be evidence of, an admission or concession by Defendants with respect to any claim of fault, liability, wrongdoing, or damage or any defect in the defenses that Individual Defendants have, or could have asserted&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">WHEREAS, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">the Parties recognize and acknowledge that (i) Plaintiffs initiated, filed, and prosecuted this Action in good faith, (ii) Defendants defended the Action in good faith, and (iii) the terms of the Settlement and this Stipulation are fair, reasonable, and adequate to the Company and its stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">NOW, THEREFORE, IT IS HEREBY STIPULATED AND AGREED,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> by and among Plaintiffs (for themselves and derivatively on behalf of Cardinal Health), the Individual Defendants, and Cardinal Health, each by and through their respective undersigned counsel, that in exchange for the consideration set forth below and the benefits flowing to the Parties from the Settlement, and subject to the approval of the Court, the Action and the Released Claims (as defined below) shall be and hereby are fully, finally, and forever settled, compromised, discharged, relinquished, and released, and the Action shall be dismissed with prejudice as to all Defendants and claims, with full preclusive effect, as to all Parties, upon and subject to the terms and conditions of the Stipulation, as set forth below.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">1.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:11.16pt">DEFINITIONS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">In addition to the terms defined elsewhere in this Stipulation, the following capitalized terms, used in this Stipulation, shall have the meanings specified below&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.1   &#8220;Action&#8221; means the above-captioned action, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">In re Cardinal Health, Inc. Derivative Litigation</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">, Case No. 2&#58;19-cv-2491, as set forth above.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.2     &#8220;Business Day&#8221; means any day other than a day on which the Court is required to close. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.3     &#8220;Cardinal Health&#8221; or the &#8220;Company&#8221; means Cardinal Health, Inc., as set forth above.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.4     &#8220;Co-Lead Counsel&#8221; means the law firms of Kessler Topaz Meltzer &#38; Check, LLP and Gardy &#38; Notis, LLP.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.5     &#8220;Current Company Stockholder&#8221; means any Person who owns Cardinal Health common stock, as of the close of trading on the date of this Stipulation.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.6     &#8220;Court&#8221; means the United States District Court for the Southern District of Ohio.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.7     &#8220;D&#38;O Insurers&#8221; means Defendants&#8217; directors and officers liability insurers, as set forth above.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.8    &#8220;Effective Date&#8221; means the date by which all of the events and conditions specified in Section 5.1 have been met and have occurred.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.9     &#8220;Fee and Expense Award&#8221; has the meaning ascribed to it in Section 4.1 below. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.10  &#8220;Final&#8221; means the time when a Judgment that has not been reversed, vacated, or modified in any way is no longer subject to appellate review, either because of a disposition on appeal and conclusion of the appellate process (including potential writ proceedings) or because of passage of time for seeking appellate or writ review without action.  More specifically, it is that situation when&#58;  (i) no appeal or petition for review by writ has been filed and the time has passed for any notice of appeal or writ petition to be timely filed from the Judgment&#59; or (ii) if an appeal is taken, the court of appeal has either affirmed the Judgment or dismissed that appeal and the time for any reconsideration or further appellate review has passed&#59; or (iii) a higher court has granted further appellate review and that court has either affirmed the underlying Judgment or affirmed the court of appeal&#8217;s decision affirming the Judgment or dismissing the appeal or writ proceeding, and the time for any reconsideration or further appellate review has passed.  For purposes of this paragraph, an appeal or proceeding seeking subsequent judicial review pertaining solely to attorneys&#8217; fees or expenses or service awards, including any Fee and Expense Award, shall not in any way delay or preclude the Judgment from becoming Final.  Any reference to the &#8220;Finality&#8221; of the Judgment shall incorporate the definition of Final in this paragraph.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.11  &#8220;Individual Defendants&#8221; means David J. Anderson, Colleen F. Arnold, George S. Barrett, Carrie S. Cox, Calvin Darden, Bruce L. Downey, Patricia A. Hemingway Hall, Akhil Johri, Clayton M. Jones, Michael C. Kaufmann, Gregory B. Kenny, Nancy Killefer, David P. King, and J. Michael Losh, as set forth above.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.12  &#8220;Judgment&#8221; means the final order and judgment to be rendered by the Court, in all material respects substantially in the form attached as </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">Exhibit B</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> hereto.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.13  &#8220;Notice&#8221; means the Notice of Pendency and Proposed Settlement of Stockholder Derivative Action, Settlement Hearing, and Right to Appear, substantially in the form attached as </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">Exhibit</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">C</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> hereto.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.14  &#8220;Parties&#8221; means Plaintiffs, Individual Defendants, and Cardinal Health, as set forth above.  &#8220;Party&#8221; means, individually, any of the Parties, as set forth above.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.15  &#8220;Person&#8221; means an individual, corporation, limited liability corporation, professional corporation, partnership, limited partnership, limited liability partnership, association, joint stock company, estate, legal representative, trust, unincorporated association, government or any political subdivision or agency thereof, or any other business or legal entity.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.16    &#8220;Plaintiffs&#8221; means Melissa Cohen, Stanley M. Malone, and Michael Splaine, as set forth above.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.17   &#8220;Plaintiffs&#8217; Counsel&#8221; means the law firms of Gardy &#38; Notis, LLP, Kessler Topaz Meltzer &#38; Check, LLP, Strauss Troy Co., LPA, Isaac Wiles Burkholder &#38; Teetor, LLC, and The Gibbs Law Group, LLP. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.18   &#8220;Preliminary Approval Order&#8221; means the order to be entered by the Court, in all material respects substantially in the form attached as </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">Exhibit</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">D</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> hereto, including, among other things, preliminarily approving the terms and conditions of the Settlement as set forth in this Stipulation, directing that notice be provided to Current Company Stockholders, and scheduling a Settlement Hearing to consider whether the Settlement, the proposed Fee and Expense Award, and service awards to Plaintiffs should be finally approved and whether the Judgment should be entered.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.19  &#8220;Related Persons&#8221; means past or present family members, spouses, heirs, trusts, trustees, executors, estates, administrators, beneficiaries, distributees, foundations, agents, employees, fiduciaries, partners, partnerships, general or limited partners or partnerships, joint ventures, member firms, limited liability companies, corporations, parents, subsidiaries, divisions, affiliates, associated entities, stockholders, principals, officers, directors, managing directors, members, managing members, managing agents, representatives, predecessors, predecessors-in-interest, successors, successors-in-interest, assigns, financial or investment advisors, advisors, consultants, investment bankers, entities providing any fairness opinion, underwriters, brokers, dealers, lenders, commercial bankers, attorneys, personal or legal representatives, accountants, insurers, co-insurers, reinsurers, and associates.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.20   &#8220;Released Claims&#8221; means, collectively, the Released Defendant Claims and the Released Plaintiff Claims.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.21  &#8220;Released Defendant Claims&#8221; means any and all claims, rights, demands, obligations, controversies, debts, disputes, damages, losses, causes of action, issues, liabilities, and charges of any kind or nature whatsoever, whether in law or equity, including both known claims and Unknown Claims, suspected or unsuspected, accrued or unaccrued, fixed or contingent, liquidated or unliquidated, matured or unmatured, foreseen or unforeseen, whether arising under federal or state statutory or common law, or any other law, rule, or regulation, whether foreign or domestic, that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">Defendants have or could have asserted against the Released Plaintiffs or their counsel, arising out of, relating to, based upon, or involving the institution, prosecution, or settlement of the claims asserted against the Individual Defendants&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">, that the Released Defendant Claims shall not include (1) any claims arising out of, based upon, or relating to the enforcement of the Settlement or this Stipulation, or (2) any claims by Defendants related to insurance coverage or the right to indemnification. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.22    &#8220;Released Defendant Persons&#8221; means, collectively, each and all of the Individual Defendants and the Company, and their respective attorneys, and each and all of their respective Related Persons.  </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.23  &#8220;Released Persons&#8221; means, collectively, the Released Defendant Persons and the Released Plaintiffs.  &#8220;Released Person&#8221; means, individually, any of the Released Persons.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.24  &#8220;Released Plaintiff Claims&#8221; means any and all claims, rights, demands, obligations, controversies, debts, disputes, damages, losses, causes of action, issues, liabilities, and charges of any kind or nature whatsoever, whether in law or equity, including both known claims and Unknown Claims, suspected or unsuspected, accrued or unaccrued, fixed or contingent, liquidated or unliquidated, matured or unmatured, foreseen or unforeseen, whether arising under federal or state statutory or common law, or any other law, rule, or regulation, whether foreign or domestic, that (i) were asserted in any of the complaints filed in the Action, or (ii) could have been, or could be, asserted by Cardinal Health directly, by Plaintiffs directly, or by Plaintiffs or any Cardinal Health stockholder derivatively on behalf of Cardinal Health, against the Released Defendant Persons in any court, tribunal, forum, or proceeding, concerning, arising from, relating to, based upon, or involving, in any way whatsoever, any of the facts, allegations, practices, events, claims, disclosures, non-disclosures, occurrences, representations, statements, matters, transactions, conduct, actions, failures to act, omissions, or circumstances that were alleged or referred to in any of the complaints filed in the Action or in the prosecution or settlement of the Action, including but not limited to any and all such claims that were, could have been, or could be asserted by Cardinal Health, Plaintiffs or any other Cardinal Health stockholder derivatively on behalf of Cardinal Health, concerning, arising from, or relating to Cardinal Health&#8217;s liabilities associated with settled, pending, or future litigation or claims of any nature concerning, arising from, or relating to the underlying facts, conduct, events, occurrences, transactions, or allegations set forth or referred to in any of the complaints, including the Amended Complaint, filed in the Action&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">, that the Released Plaintiff Claims shall not include any claims arising out of, based upon, or relating to the enforcement of the Settlement or this Stipulation.  For the avoidance of doubt, the Released Plaintiff Claims do not cover, settle, or release any direct claims held by any current, former, or future Cardinal Health stockholder other than Plaintiffs, including any claims asserted under the federal or state securities laws. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.25    &#8220;Released Plaintiffs&#8221; means each and all of the Plaintiffs and their respective attorneys, and each and all of their respective Related Persons.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.26  &#8220;Settlement&#8221; means the settlement by and among the Parties on the terms and conditions set forth in this Stipulation. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.27  &#8220;Settlement Amount&#8221; means one hundred twenty four million dollars ($124,000,000) in cash to be paid by Defendants&#8217; D&#38;O Insurers.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.28    &#8220;Settlement Hearing&#8221; means the hearing to be held by the Court upon duly given notice to review this Stipulation and its exhibits, as well as the application for the Fee and Expense Award, and determine whether the Settlement should be finally approved, whether the Fee and Expense Award should be finally approved, whether service awards to Plaintiffs should be paid from any such award, and whether the Judgment should be entered.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.29    &#8220;Summary Notice&#8221; means the Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Action, substantially in the form attached as </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">Exhibit</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">E</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> hereto. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">1.30    &#8220;Unknown Claims&#8221; means any Released Claims that any of the Parties or any Cardinal Health stockholder does not know or suspect to exist in his, her, or its favor at the time of the release of such claims, including claims which, if known by him, her, or it, might have affected his, her, or its decision to settle or the terms of his, her, or its settlement with and releases provided to the other Parties, or might have affected his, her, or its decision not to object to this Settlement.  With respect to any and all Released Claims, the Parties stipulate and agree that, upon the Effective Date, the Parties shall expressly waive, and, with respect to Released Plaintiff Claims that could have been or could be asserted derivatively on behalf of the Company, all other Cardinal Health stockholders by operation of the Judgment shall have expressly waived, the provisions, rights, and benefits of California Civil Code &#167; 1542, or any other law of the United States or any state or territory of the United States, or principle of common law or foreign law that is similar, comparable, or equivalent to Section 1542, which provides&#58;</font></div><div style="padding-left:117pt;padding-right:85.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.</font></div><div style="padding-left:72pt;padding-right:85.5pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">The Parties and each Cardinal Health stockholder may hereafter discover facts in addition to or different from those which he, she, or it now knows or believes to be true with respect to the subject matter of the Released Claims, known or unknown, suspected or unsuspected, contingent or non-contingent, whether or not concealed or hidden, which now exist, or heretofore have existed upon any theory of law or equity, but the Parties and each Cardinal Health stockholder derivatively on behalf of the Company shall expressly, fully, finally, and forever settle and release, and upon the Effective Date and by operation of the Judgment shall have settled and released, fully, finally, and forever, any and all Released Claims as applicable without regard to the subsequent discovery or existence of such different or additional facts.  The Parties acknowledge, and the Cardinal Health stockholders shall be deemed by operation of the Judgment </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">to have acknowledged, that the foregoing waiver was separately bargained for and is a key element of the Settlement of which this release is a part.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">2.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:11.16pt">SETTLEMENT CONSIDERATION</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">2.1    In consideration for the full and final release, settlement, and discharge of any and all Released Plaintiff Claims against the Released Defendant Persons and the dismissal with prejudice of the Action on the terms and conditions set forth in this Stipulation&#58; </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">(a)    Defendants shall cause their D&#38;O Insurers to pay the Settlement Amount, less any Fee and Expense Award paid to Plaintiffs&#8217; Counsel pursuant to Section 4.2, to the Company, by wire transfer or check at the option of the D&#38;O Insurers, no later than twenty (20) Business Days after the later of (1) the Court&#8217;s order approving the Settlement and entering the Judgment pursuant to Section 5.1(a)-(b)&#59; and (2) receipt of payee information, check and&#47;or wire instructions as applicable, and tax identification information for the payment from the Company&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">(b)   to the extent the Settlement is terminated or cancelled pursuant to any of the conditions set forth in Section 5.2, the Company shall make a full refund to the D&#38;O Insurers of the payment the Company received under Section 2.1(a), no later than twenty (20) Business Days after the Settlement has been so terminated or cancelled, and such refund will be distributed to the D&#38;O Insurers in accordance with the provisions of separate funding agreements between Defendants and the D&#38;O Insurers entered into in connection with the Settlement. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">2.2    Defendants&#8217; D&#38;O Insurers&#8217; payment of the Settlement Amount as provided in Sections 2.1(a) and 4.2 of this Stipulation shall constitute full and final satisfaction of all of the Released Plaintiff Claims.  Defendants&#8217; sole monetary obligation under the Settlement shall be to cause to be paid the Settlement Amount by their D&#38;O Insurers as provided in this Stipulation, and they shall not be liable for any other amounts, including any Court-awarded attorneys&#8217; fees and litigation expenses to Plaintiffs&#8217; Counsel, which shall be paid, if awarded, out of the Settlement Amount.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">3.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:11.16pt">SUBMISSION OF THE SETTLEMENT TO THE COURT FOR APPROVAL</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">3.1     As soon as practicable after this Stipulation has been executed, Plaintiffs&#8217; Counsel shall submit this Stipulation, together with its exhibits, to the Court and file a motion for preliminary approval of the Settlement, requesting, among other things&#58;  (i) preliminary approval of the Settlement set forth in this Stipulation and entry of the Preliminary Approval Order substantially in the form attached as </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">Exhibit D </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">hereto&#59; (ii) approval of the method of providing notice to Current Company Stockholders and approval of the forms of Notice and Summary Notice attached as </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">Exhibits C </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">and</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%"> E </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">hereto&#59; and (iii) a date for the Settlement Hearing.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">3.2     The proposed Preliminary Approval Order provides that, within ten (10) Business Days following the entry of a Preliminary Approval Order (the &#8220;Notice Date&#8221;), the Company shall&#58;  (i) file a Form 8-K with the SEC that includes the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">Notice as an attachment&#59; (ii) post this Stipulation and the Notice on the investor relations section of the Company&#8217;s website until the Effective Date of the Settlement&#59; and (iii) issue a press release on PR Newswire or other equivalent national press release service that includes the Summary Notice.  The proposed Preliminary Approval Order also provides that, within ten (10) Business Days of the Notice Date, the Company shall cause the Summary Notice to be published in </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">The Wall Street Journal</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">.  The Company shall assume all administrative responsibility for and will pay any and all costs of notice of the Settlement by these methods, regardless of whether the Court approves the Settlement or the Effective Date fails to occur.  Neither Plaintiffs nor Plaintiffs&#8217; Counsel shall be responsible for any costs of notice of the Settlement, except that Co-Lead Counsel shall also make copies of the Notice and Summary Notice available on their respective websites, and shall bear the administrative responsibility for such posting and any costs thereof.   </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">3.3      The Parties believe the content and manner of the Notice and Summary Notice, as set forth in Sections 3.1 and 3.2, constitutes adequate and reasonable notice pursuant to applicable law and due process.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">3.4     The Parties agree to request that the Court hold a hearing in the Action no earlier than sixty (60) days after notice is given, at which time the Court will consider and determine whether the Judgment, substantially in the form of </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">Exhibit B </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">hereto, should be entered&#58;  (i) approving the terms of the Settlement as fair, reasonable, and adequate&#59; (ii) dismissing with prejudice the Action&#59; (iii) ruling upon Plaintiffs&#8217; application for a Fee and Expense Award&#59; and (iv) ruling upon Plaintiffs&#8217; request for service awards.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">3.5     Pending the Effective Date, the Parties agree that all proceedings and discovery in the Action shall be stayed (except as otherwise provided herein and in the proceedings necessary to effectuate the consummation and final approval of the Settlement) and not to initiate any other proceedings other than those related to the Settlement itself.  The Parties shall not file, prosecute, instigate, or in any way participate in the commencement or prosecution of any of the Released Claims.  The Parties shall cooperate to secure a postponement of any response deadline, hearing, or trial date(s) in the Action while this Settlement is under consideration by this Court. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">4.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:11.16pt">FEE AND EXPENSE AWARD</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">4.1      In recognition of Plaintiffs&#8217; Counsel&#8217;s role in prosecuting and settling the Action, Cardinal Health agrees that Co-Lead Counsel should receive a fee and expense award totaling 25% of the Settlement Amount, subject to Court approval (the &#8220;Fee and Expense Award&#8221;).  Plaintiffs and Plaintiffs&#8217; Counsel agree not to request any greater amount be awarded to Plaintiffs&#8217; Counsel by the Court and not to seek the payment of attorneys&#8217; fees and expenses from any person or entity other than Cardinal Health or Defendants&#8217; D&#38;O Insurers.  Co-Lead Counsel also intend to seek Court approval of service awards for Plaintiffs of $2,500 each, which, if approved, will be paid out of the Fee and Expense Award.  </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">4.2      The Parties acknowledge and agree that any Fee and Expense Award in connection with the Settlement shall be paid by Defendants&#8217; D&#38;O Insurers to Co-Lead Counsel, via wire transfer or check at the option of the D&#38;O Insurers, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">from the Settlement Amount, no later than twenty (20) Business Days after the later of (i) the date of entry of the Court&#8217;s order awarding such fees and expenses&#59; and (ii) receipt of payee information, check and&#47;or wire instructions as applicable, and tax identification information for the payment from Co-Lead Counsel.  Any Fee and Expense Award shall be paid out of, and not be in addition to, the Settlement Amount.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">4.3      The payment of any Fee and Expense Award to Co-Lead Counsel shall be subject to the joint and several obligation of Co-Lead Counsel to&#58; </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">(a)     in the event the Settlement is terminated or cancelled pursuant to Section 5.2, make full refund of any such payment to the D&#38;O Insurers, which will be distributed to the D&#38;O Insurers in accordance with instructions to be provided by the Individual Defendants&#8217; counsel consistent with the provisions of separate funding agreements between Defendants and the D&#38;O Insurers entered into in connection with the Settlement&#59; and </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">(b)     in the event the Fee and Expense Award is reduced or reversed as a result of any appeal or further proceedings on remand or successful collateral attack and such order reducing or reversing the award has become final, pay to Cardinal Health, in accordance with instructions to be provided by Cardinal Health&#8217;s counsel, the portion of any such reduction or reversal.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">4.4      Co-Lead Counsel, in their sole discretion, shall be responsible for distributing the Fee and Expense Award among Plaintiffs&#8217; Counsel.  Any fees or expenses associated with Co-Lead Counsel&#8217;s distribution of the Fee and Expense Award shall be borne solely by Co-Lead Counsel.  Defendants and their respective counsel shall have no responsibility for, and no liability whatsoever with respect to, the distribution or allocation of the Fee and Expense Award.  Any dispute regarding the distribution or allocation of the Fee and Expense Award shall have no effect on the Settlement or the Releases. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">4.5       Except as otherwise provided herein or except as provided pursuant to indemnification or insurance rights, each of the Parties shall bear his, her, or its own costs, expenses, and attorneys&#8217; fees.   </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">4.6         The amount of any Fee and Expense Award shall be subject to Court approval.  The Court may consider and rule upon the fairness, reasonableness, and adequacy of the Settlement independently of the consideration of any Fee and Expense Award.  Any changes by any court, including this Court, to the negotiated amount of any Fee and Expense Award, or to any service awards, will not otherwise affect the Finality of the Judgment or the validity of the Settlement, and the Parties&#8217; obligations under the Settlement (except with respect to the payment of attorneys&#8217; fees and expenses) shall not be conditioned on the resolution of, nor any ruling regarding, any Fee and Expense Award, including any service awards.  Any orders or proceedings relating to any request for a Fee and Expense Award or service award, or any appeal from any order or proceedings relating thereto, shall not affect the validity of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">Settlement, operate to terminate or cancel the Stipulation, and&#47;or affect or delay either the Effective Date or the Finality of the Judgment approving the Settlement.     </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">5.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:11.16pt">CONDITIONS OF SETTLEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">5.1       The Effective Date of the Settlement shall be the date on which all of the following events have occurred&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">(a)     approval of the Settlement at or after the Settlement Hearing following notice to Current Company Stockholders as set forth in Section 3.2&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">(b)      entry of the Judgment, in all material respects in the form set forth as </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">Exhibit B </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">annexed hereto, approving the Settlement without the award of any damages, costs, or fees to any Party, except as provided for in this Stipulation&#59; dismissing the Action with prejudice pursuant to the terms of this Stipulation&#59; and releasing the Released Persons from the Released Claims&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">(c) the passing of the date upon which the Judgment, including dismissal of the Action with prejudice pursuant to the terms of this Stipulation, becomes Final.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> 5.2       If (i) the Court has refused to grant approval of the Settlement in any material respect, (ii) the Court alters the Judgment in any material respect prior to entry, or (iii) the Court enters the Judgment, but on or following appellate review, the Judgment is modified or reversed in any material respect, then this Stipulation and the Settlement shall be canceled and terminated, and the Judgment and any other order entered by the Court in accordance with the terms of this Stipulation and the Settlement shall be treated as vacated, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">nunc pro tunc</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">, unless each of the Parties to this Stipulation, within ten (10) Business Days from receipt of such ruling, agrees in writing to proceed with the Settlement, including only with such modifications, if any, as to which all Parties agree&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">, that any such refusal, alteration, modification, or reversal with respect to any Fee and Expense Award or service award shall not be considered material to the Settlement, shall not affect the Finality of the Judgment, and shall not be grounds for cancelation or termination of this Stipulation and the Settlement.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> 5.3     If this Stipulation and the Settlement is canceled or terminated pursuant to Section 5.2 above, or fails to become Final in accordance with its terms or the Effective Date otherwise fails to occur, then&#58;  (i) the Settlement and the relevant portions of this Stipulation shall be canceled&#59; (ii) Cardinal Health and Co-Lead Counsel shall comply with their repayment obligations set forth in Sections 2.1(b) and 4.3(a)&#59; (iii) the Parties shall be deemed to have reverted to their respective litigation status in the Action as of the date this Stipulation was executed&#59; (iv) the terms and provisions of the Settlement and this Stipulation, with the exception of this Section 5.3, and Sections 2.1(b), 4.3(a), 7.1, 12.9, and 12.10, shall have no further force and effect with respect to the Parties and shall not be used in the Action or in any other proceeding for any purpose, and the Parties shall proceed in all respects as if the Settlement and this Stipulation had not been entered&#59; and (v) the Judgment and any other order entered by the Court in accordance with the terms of this Stipulation shall be treated as vacated, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">nunc pro tunc.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">6.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:11.16pt">DISMISSAL OF ACTION AND RELEASE OF CLAIMS</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">6.1    This Settlement is conditioned on the dismissal with prejudice of the Action at the time of final approval by the Court.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">6.2    Plaintiffs shall provide reasonable documentary assistance to Defendants as requested to assist Defendants&#8217; efforts to obtain dismissal of any stockholder derivative actions not listed above as part of the Action that may be later filed in any state or federal court asserting any of the Released Plaintiff Claims against the Released Defendant Persons.  </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">6.3    Pursuant to the Judgment, without further action by anyone, upon the Effective Date, Cardinal Health acting directly, Plaintiffs acting directly on behalf of themselves and derivatively on behalf of Cardinal Health, and any other Cardinal Health stockholder acting derivatively on behalf of Cardinal Health, and any of their respective legal representatives, heirs, executors, administrators, predecessors, successors, predecessors-in-interest, successors-in-interest and assigns, shall be deemed to have, and by operation of the Judgment, shall have, fully, finally, and forever released, relinquished, settled, discharged, and dismissed with prejudice every one of the Released Plaintiff Claims (including Unknown Claims) against the Released Defendant Persons, and shall be forever barred and enjoined from asserting, commencing, instituting, prosecuting, or continuing to prosecute any of the Released Plaintiff Claims against any of the Released Defendant Persons.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">6.4     Pursuant to the Judgment, without further action by anyone, upon the Effective Date, each of the Individual Defendants and Cardinal Health, and their respective legal representatives, heirs, executors, administrators, predecessors, successors, predecessors-in-interest, successors-in-interest and assigns, shall be deemed to have, and by operation of the Judgment, shall have, fully, finally, and forever released, relinquished, settled, discharged, and dismissed with prejudice every one of the Released Defendant Claims (including Unknown Claims) against the Released Plaintiffs, and shall be forever barred and enjoined from asserting any Released Defendant Claims against any of the Released Plaintiffs. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">6.5       Nothing herein or in the Judgment shall in any way impair or restrict the rights of any Party to enforce the terms of this Stipulation, the Settlement, or the Judgment.   </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">7.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:11.16pt">NO ADMISSION OF WRONGDOING</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">7.1       Neither this Stipulation (whether or not consummated), including the exhibits hereto, the negotiations leading to the execution of the Settlement, nor any proceedings taken pursuant to or in connection with the Settlement, this Stipulation, and&#47;or approval of the Settlement (including any arguments proffered in connection therewith)&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">(a)     shall be offered against any of the Released Defendant Persons as evidence of, or construed as, or deemed to be evidence of any presumption, concession, or admission by any of the Released Defendant Persons with respect to the truth of any fact alleged by Plaintiffs or the validity of any claim that was or could </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">have been asserted or the deficiency of any defense that has been or could have been asserted in the Action or in any other litigation, or of any liability, negligence, fault, or other wrongdoing of any kind of any of the Released Defendant Persons, or in any way referred to for any other reason as against any of the Released Defendant Persons, in any action or proceeding, other than such proceedings as may be necessary to effectuate the provisions of this Stipulation&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">(b)    shall be offered against any of the Released Plaintiffs as evidence of, or construed as, or deemed to be evidence of any presumption, concession, or admission by any of the Released Plaintiffs that any of the Released Plaintiff Claims are without merit, that any of the Released Defendant Persons had meritorious defenses, or that damages recoverable under the Amended Complaint would not have exceeded the Settlement Amount, or with respect to any liability, negligence, fault, or wrongdoing of any kind, or in any way referred to for any other reason as against any of the Released Plaintiffs, in any action or proceeding, other than such proceedings as may be necessary to effectuate the provisions of this Stipulation&#59; or </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">(c)     shall be construed against any of the Released Persons as an admission, concession, or presumption that the consideration to be given hereunder represents the amount which could be or would have been recovered after trial&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:200%">provided, however, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">that if this Stipulation is approved by the Court, the Parties, the Released Persons, and their respective counsel, may refer to the Stipulation (including the exhibits thereto) to effectuate the protections from liability granted hereunder or otherwise to enforce the terms of the Settlement.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">8.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:11.16pt">NO WAIVER</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">8.1     Any failure by any Party to this Stipulation to insist upon the strict performance by any other Party to this Stipulation of any of the provisions of this Stipulation shall not be deemed a waiver of any of the provisions hereof, and such Party, notwithstanding such failure, shall have the right thereafter to insist upon the strict performance of any and all of the provisions of this Stipulation to be performed by such other Party.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">8.2       No waiver, express or implied, by any party to this Stipulation of any breach or default by any other Party to this Stipulation in the performance by the other Party of its obligations under this Stipulation shall be deemed or construed to be a waiver of any other breach, whether prior, subsequent, or contemporaneous, under this Stipulation.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">9.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:11.16pt">RETENTION OF JURISDICTION AND PREVAILING PARTY</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">9.1     The Court shall retain exclusive jurisdiction with respect to the interpretation, implementation, and enforcement of the terms of this Stipulation, and the Parties and their undersigned counsel submit to the jurisdiction of the Court for purposes of implementing and enforcement of the Settlement embodied in this Stipulation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">In any action brought to enforce the terms of this Stipulation and the Settlement contemplated by it, the party prevailing on any claim, matter, or issue shall be entitled to recover from the losing party all reasonable fees, expenses, and costs, including, but not limited to, attorneys&#8217; fees, incurred in bringing such claim, matter, or issue.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">10.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:6.6pt">RIGHT TO INJUNCTIVE RELIEF</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">10.1   The Parties acknowledge and agree that (i) any breach of this Stipulation may result in immediate and irreparable injury for which there is no adequate remedy available at law and (ii) in addition to any other remedies available, specific performance and injunctive relief are appropriate remedies to compel performance of this Stipulation.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">11.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:6.6pt">SUCCESSORS AND ASSIGNS </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">11.1     This Stipulation is and shall be binding upon, and shall inure to the benefit of, the Parties (and, in the case of the releases, all Released Persons as third-party beneficiaries) and their respective legal representatives, heirs, executors, administrators, predecessors, successors, predecessors-in-interest, successors-in-interest, and assigns of any of the foregoing, including, but not limited to, any corporation or other entity with which any party hereto may merge, reorganize or otherwise consolidate.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">12.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:6.6pt">MISCELLANEOUS</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.1    The Parties (i) acknowledge that it is their intent to consummate the Settlement&#59; and (ii) agree to act in good faith and cooperate fully with one another to take all reasonable and necessary steps to expeditiously implement the terms and conditions of the Settlement set forth in this Stipulation.  The Parties agree to use their reasonable best efforts to obtain the Court&#8217;s approval of this Stipulation and the Settlement and a dismissal with prejudice of the Action (including, but not limited to, resolving any objections raised to the Settlement).  The Parties represent and agree that the terms of this Stipulation and the Settlement were negotiated at arm&#8217;s-length and in good faith, and reflect a settlement that was reached voluntarily based upon adequate information and sufficient discovery and after consultation with experienced legal counsel.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.2     All of the exhibits attached hereto are material and integral parts hereof and shall be incorporated by reference as though fully set forth herein.  Notwithstanding the foregoing, in the event that there exists a conflict or inconsistency between the terms of this Stipulation and the terms of any exhibit attached hereto, the terms of the Stipulation shall prevail.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.3     This Stipulation and the exhibits hereto constitute the entire agreement among the Parties with respect to the Settlement and this Stipulation and its exhibits, and supersede any and all prior negotiations, discussions, agreements, or undertakings with respect to such matters, and may not be amended or modified, nor may any of its provisions be waived, except by a writing signed by or on behalf of all of the Parties hereto or their successors-in-interest.  All Parties acknowledge that, in entering into this Stipulation and Settlement, they are not relying upon any statements, agreements, representations, warranties, or inducements by any Party except as expressly set forth in this Stipulation.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.4     Plaintiffs represent and warrant that they have not assigned or transferred or attempted to assign or transfer, to any Person any Released Plaintiff Claims or any portion thereof or interest therein.  </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.5     The headings herein are used for the purpose of convenience only and are not meant to have legal effect.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.6     The Stipulation and the exhibits attached hereto shall be considered to have been negotiated, executed, and delivered, and to be wholly performed, in the State of Ohio, and the rights and obligations of the Parties to the Stipulation shall be construed and enforced in accordance with, and governed by, the internal, substantive laws of Ohio without giving effect to that State&#8217;s choice-of-law principles.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.7     This Stipulation may be executed in one or more counterparts, each of which so executed shall be deemed to be an original and such counterparts together constitute one and the same Stipulation.  The Parties agree that signatures submitted through facsimile or by e-mailing .PDF files or signed using DocuSign shall constitute original and valid signatures.  </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.8     Without further order of the Court, the Parties may agree to reasonable extensions of time to carry out the provisions of this Stipulation through written agreement signed by counsel for all Parties.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.9       To the extent permitted by law, all designations and agreements made and orders entered during the course of or in the Action relating to the confidentiality of documents or information shall survive this Stipulation and the Settlement, and any termination thereof.  Nothing in this Stipulation, or the negotiations relating thereto, is intended to or shall be deemed to constitute a waiver of any applicable privilege, including, without limitation, the attorney-client privilege, the joint defense privilege, or work product protection.   </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.10      Whether or not the Stipulation and the Settlement is approved by the Court and whether or not the Stipulation and the Settlement is consummated, or the Effective Date occurs, the Parties and their counsel shall use their reasonable best efforts to keep all negotiations, discussions, and drafts in connection with the Stipulation and the Settlement confidential.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.11      This Stipulation shall be treated as jointly drafted and will not be construed against any Party as the drafter.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.12    All counsel and any other person executing this Stipulation and any of the exhibits hereto, or any related Settlement documents, warrant and represent that they have the full authority to do so and that they have the authority to take appropriate action required or permitted to be taken pursuant to the Stipulation to effectuate its terms.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">12.13    Any Party may give notice or service to another Party under this Stipulation.  Such notice shall be in writing and shall be deemed to have been duly given upon receipt of hand delivery or email transmission, with confirmation of receipt.  Notice shall be provided as follows&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.307%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For Plaintiffs&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Justin O. Reliford <br>KESSLER TOPAZ MELTZER &#38; CHECK, LLP <br>280 King of Prussia Road <br>Radnor, PA 19087 <br>jreliford&#64;ktmc.com <br></font><font style="font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer Sarnelli <br>GARDY &#38; NOTIS, LLP <br>156 East 56th Street, 8th Floor <br>New York, NY 10022 <br>jsarnelli&#64;gardylaw.com</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For Individual Defendants&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert W. Trafford <br>Porter Wright Morris &#38; Arthur LLP <br>41 South High Street <br>Suites 2800 - 3200 <br>Columbus, OH 43215 <br>rtrafford&#64;porterwright.com <br></font><font style="font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William Savitt <br>Wachtell, Lipton, Rosen &#38; Katz <br>51 West 52nd Street <br>New York, NY 10019 <br>WDSavitt&#64;wlrk.com</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For Cardinal Health&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Albert G. Lin<br>Baker Hostetler<br>200 Civic Center Drive, Suite 1200<br>Columbus, OH 43215<br>alin&#64;bakerlaw.com</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:200%">IN WITNESS WHEREOF, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:200%">the Parties hereto have caused this Stipulation to be executed, by their duly authorized attorneys, as of May 25th, 2022.</font></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">KESSLER TOPAZ MELTZER &#38; CHECK, LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">____________________________</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lee Rudy</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Eric L. Zagar</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Justin O. Reliford</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">280 King of Prussia Road</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Radnor, PA 19087</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Phone&#58; (610) 667-7706</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fax&#58; (610) 667-7056</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; lrudy&#64;ktmc.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; ezagar&#64;ktmc.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; jreliford&#64;ktmc.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Co-Lead Counsel Plaintiffs</font></div><div><font><br></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">GARDY &#38; NOTIS, LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">____________________________</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">James S. Notis</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Jennifer Sarnelli</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Meagan Farmer</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">126 East 56th Street, 8th Floor</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">New York, NY 10022</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Phone&#58; (212) 905-0509</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fax&#58; (212) 905-0508</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; jnotis&#64;gardylaw.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; jsarnelli&#64;gardylaw.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; mfarmer&#64;gardylaw.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Co-Lead Counsel Plaintiffs</font></div><div><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">THE GIBBS LAW GROUP, LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">____________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mark H. Troutman (0076390), </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Trial Attorney*</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Shawn K. Judge (0069493)*</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">505 14th Street, Suite 1110</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Oakland, CA 94612</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Phone&#58; (510) 350-9700</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; mht&#64;classlawgroup.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; sklj&#64;classlawgroup.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*Working from Ohio offices</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Trial Counsel for Plaintiffs</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">STRAUSS TROY CO., LPA</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">____________________________</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Richard S. Wayne (0022390)</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">William K. Flynn (0029536)</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Robert R. Sparks (0073573)</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">150 E. Fourth Street</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cincinnati, OH 45202-4018</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Phone&#58; (513) 621-2120</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fax&#58; (513) 629-9426</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; rswayne&#64;strausstroy.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; wkflynn&#64;strausstroy.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; rrsparks&#64;strausstroy.com</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Liaison Counsel for Plaintiffs</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">WACHTELL LIPTON ROSEN &#38; KATZ</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">____________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">William Savitt</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lauren M. Kofke</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alexandra P. Sadinsky</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">51 West 52nd Street</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">New York, NY 10019</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Phone&#58; (212) 403-1000</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fax&#58; (212) 403-2000</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; wdsavitt&#64;wlrk.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; lmkofke&#64;wlrk.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; apsadinsky&#64;wlrk.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Counsel for the Individual Defendants</font></div><div><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PORTER, WRIGHT, MORRIS &#38; ARTHUR LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">____________________________</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Robert W. Trafford (0024447)</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Trial Attorney</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">David S. Bloomfield, Jr. (0068158)</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">41 South High Street, Suite 2800</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Columbus, OH 43215</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Phone&#58; (614) 227-2000</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fax&#58; (614) 227-2100</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; rtrafford&#64;porterwright.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; dbloomfield&#64;porterwright.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Counsel for the Individual Defendants</font></div><div><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">BAKER &#38; HOSTETLER LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">____________________________</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Albert G. Lin (0076888)</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Trial Attorney</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Trischa Snyder Chapman (0086420)</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Marissa A. Peirsol (0098203)</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Erika Dackin Prouty (0095821)</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">200 Civic Center Drive, Suite 1200</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Columbus, OH 43215</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Phone&#58; (614) 228-1541</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fax&#58; (614) 462-2616</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; alin&#64;bakerlaw.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; tchapman&#64;bakerlaw.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; mpeirsol&#64;bakerlaw.com</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Email&#58; eprouty&#64;bakerlaw.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Counsel for Nominal Defendant</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit992-8xk.htm
<DESCRIPTION>EX-99.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i71457bf499684c19ba84cbc9a2652600_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Notice to Cardinal Health, Inc. Stockholders of Proposed Settlement of Stockholder Derivative Action, Settlement Hearing, and Right to Appear</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">The United States District Court for the Southern District of Ohio authorized this Notice  </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Please read this notice (the &#8220;Notice&#8221;) carefully and in its entirety.  This Notice relates to a proposed settlement (the &#8220;Settlement&#8221;)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of a consolidated stockholder derivative action (the &#8220;Action&#8221;) brought on behalf of Cardinal Health, Inc. (&#8220;Cardinal Health&#8221; or the &#8220;Company&#8221;) and pending in the United States District Court for the Southern District of Ohio, Eastern Division (the &#8220;Court&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Notice contains important information.  Your rights will be affected by these legal proceedings.  If the Court approves the Settlement, you will be forever barred from contesting the fairness, reasonableness, and adequacy of the Settlement and related matters, and from pursuing the Released Claims (as defined herein).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Settlement is approved by the Court, Cardinal Health will receive a $124 million cash payment, less any payments and expenses as described below.  Please note that the Action is a derivative action where the legal claims were brought by Cardinal Health stockholders derivatively on behalf of, and for the benefit of, Cardinal Health itself.  As a result, the Settlement provides that the cash recovery will be paid directly to Cardinal Health.  You will not receive any direct payment, and do not need to submit any claim form in connection with the Settlement. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Why this Notice&#63;</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">You have a right to know about the Settlement of the Action, and about all of your options, before the Court decides whether to approve the Settlement.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Notice summarizes the Action, the Settlement, and your legal rights.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Court in charge of the Action is the United States District Court for the Southern District of Ohio, Eastern Division, and the case is called </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In re Cardinal Health, Inc. Derivative Litigation</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Case No. 2&#58;19-cv-2491</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  The judge presiding over the Action is Judge Sarah D. Morrison.  The stockholders who brought the Action are called the Plaintiffs,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and the people who the stockholders have sued are called the Individual Defendants.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The Action is a derivative action, which means that the Plaintiffs seek to pursue legal claims on behalf of, and for the benefit of, Cardinal Health itself and not any stockholders directly.  Cardinal Health is named in the Action as a &#8220;Nominal Defendant&#8221; only, and there are no claims asserted against Cardinal Health.  This Notice refers to Individual Defendants and Nominal Defendant collectively as the &#8220;Defendants,&#8221; and Plaintiffs and Defendants collectively as the &#8220;Parties.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Court will hold a hearing (the &#8220;Settlement Hearing&#8221;) to decide if the Settlement is fair and reasonable.  If the Court approves the Settlement and the Settlement becomes effective, the Action will be dismissed with prejudice.  If you were a stockholder of Cardinal Health as of the close of trading on the date of the Stipulation (May 25, 2022) and you continue to own such stock through the date of the Settlement Hearing, you have the right to tell the Court your opinion about the Settlement.  Please see below for more details about how and when to file your opinion with the Court, if you so choose.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">What is this Action about&#63;</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following recitation does not constitute findings of the Court and should not be understood as an expression of any opinion of the Court as to the merits of any claims or defenses by any of the Parties. </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All capitalized terms used in this Notice that are not otherwise defined herein shall have the meanings provided in the Stipulation and Agreement of Compromise, Settlement, and Release, dated May 25, 2022 (the &#8220;Stipulation&#8221;).</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs are Melissa Cohen, Stanley M. Malone, and Michael Splaine.  &#8220;Plaintiffs&#8217; Counsel&#8221; consist of Gardy &#38; Notis, LLP and Kessler Topaz Meltzer &#38; Check, LLP, together acting as Co-Lead Counsel, and Isaac Wiles Burkholder &#38; Teetor, LLC, Gibbs Law Group, LLP, and Strauss Troy Co., LPA.  </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual Defendants are current and former members of Cardinal Health&#8217;s Board of Directors&#58;  David J. Anderson, Colleen F. Arnold, George S. Barrett, Carrie S. Cox, Calvin Darden, Bruce L. Downey, Patricia A. Hemingway Hall, Akhil Johri, Clayton M. Jones, Michael C. Kaufmann, Gregory B. Kenny, Nancy Killefer, David P. King, and J. Michael Losh (collectively, &#8220;Individual Defendants&#8221;).  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Between June 14, 2019 and January 13, 2020, Plaintiffs filed three separate actions that the Court consolidated into the Action on January 28, 2020.  Plaintiffs obtained confidential internal documents from Cardinal Health as permitted under Ohio law and, on March 12, 2020, filed an amended complaint (the &#8220;Amended Complaint&#8221;), which is the operative complaint in the Action.  The Amended Complaint alleged that the Individual Defendants breached their fiduciary duties under Ohio law by allegedly failing to properly oversee the Company&#8217;s compliance with controlled substances regulations and by allegedly approving improper compensation and bonuses to Company executives who allegedly failed to ensure compliance with such regulations.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Defendants asked the Court to dismiss the Action, and Plaintiffs opposed the request.  Defendants and Plaintiffs presented arguments to the Court.  On February 8, 2021, the Court dismissed the compensation-related claim, but declined to dismiss the oversight claim related to the Company&#8217;s compliance with controlled substances regulations.  The Court did not make, and has not made, any final decisions about the merits of the surviving claim.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">After the Court&#8217;s ruling, Plaintiffs continued to investigate their claims and obtain additional discovery.  Between April 30, 2021 and December 1, 2021, Cardinal Health produced to Plaintiffs more than 15 million pages of documents, including deposition transcripts and written discovery responses from the &#8220;MDL&#8221; proceedings.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Defendants also provided written responses to Plaintiffs&#8217; discovery demands in the Action.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Parties engaged the Hon. Daniel Weinstein (Ret.) and Jed D. Melnick, Esq. to act as private mediators to assist the Parties in negotiating a potential resolution.  On December 9, 2021, counsel for the Parties and representatives of Defendants&#8217; directors and officers liability insurers (&#8220;D&#38;O Insurers&#8221;) participated in a mediation session, during which the Parties agreed in principle to settle the Action in return for a cash payment of one hundred twenty-four million dollars ($124,000,000), to be paid by the D&#38;O Insurers to the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Settlement also provides that any fees and expenses to Plaintiffs&#8217; Counsel would be paid exclusively from the $124 million Settlement amount.  As those costs would reduce the net payment received by Cardinal Health, after the substantive terms of the Settlement were negotiated and agreed to, the Parties separately negotiated in good faith as to an appropriate amount of attorneys&#8217; fees and expenses that Cardinal Health agreed was appropriate for Plaintiffs&#8217; Counsel&#8217;s role in prosecuting the Action.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following those negotiations, Cardinal Health has agreed, subject to approval of the Court, that Plaintiffs&#8217; Counsel are entitled to a fee and expense award of 25% of the Settlement amount (the &#8220;Fee and Expense Award&#8221;).  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The full terms and conditions of the Settlement, the Fee and Expense Award, and related matters are embodied in the Stipulation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 18, 2022, the Court preliminarily approved the Settlement, authorizing this Notice and scheduling the Settlement Hearing to consider whether to grant final approval of the Settlement, the Fee and Expense Award, and related matters (the &#8220;Preliminary Approval Order&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Why is there a Settlement and what are the terms&#63;</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Plaintiffs and Plaintiffs&#8217; Counsel believe that the claims raised in the Action have merit and that their investigation supports the claims asserted.  Without conceding the merit of any of Defendants&#8217; defenses, and in light of the benefits of the Settlement as well as to avoid the potentially protracted time, expense, and uncertainty associated with continued litigation, including potential trial and appeal(s), Plaintiffs and Plaintiffs&#8217; Counsel have concluded that it is desirable that the Action be fully and finally settled in the manner and upon the terms and conditions set forth in the Stipulation. Plaintiffs and Plaintiffs&#8217; Counsel recognize the significant risk, expense, and length of continued proceedings necessary to prosecute the Action against Defendants through trial and through possible appeal(s).  Plaintiffs&#8217; Counsel have also taken into account the uncertain outcome and the risk of any litigation, especially complex litigation such as would be entailed by the Action, the difficulties and delays inherent in such </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;MDL&#8221; refers to consolidated proceedings of cases filed by state and local governments, tribal sovereign nations and others against various defendants, including Cardinal Health, that the U.S. Judicial Panel on Multi-District Litigation centralized and transferred into a multi-district litigation called </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re National Prescription Opiate Litigation</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. MDL 2804 in the United States District Court for the Northern District of Ohio in December 2017.  On July 21, 2021, Cardinal Health announced that it, McKesson Corporation (&#8220;McKesson&#8221;), and AmerisourceBergen Corporation (&#8220;AmerisourceBergen&#8221;), had entered into a settlement to resolve the vast majority of opioid lawsuits filed by state and local government entities.  That settlement was binding as of February 25, 2022 and effective as of April 2, 2022, and includes injunctive relief terms relating to the settling distributors&#8217; controlled substance anti-diversion programs that have been implemented on or before July 1, 2022. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">litigation, the cost to Cardinal Health &#8211; on behalf of which Plaintiffs filed the Action &#8211; and distraction to management of Cardinal Health that would result from extended litigation.  Based on their evaluation, and in light of what Plaintiffs and Plaintiffs&#8217; Counsel believe to be the significant benefits conferred upon Cardinal Health as a result of the Settlement, Plaintiffs and Plaintiffs&#8217; Counsel have determined that the Settlement is in the best interests of Plaintiffs, Cardinal Health, and Cardinal Health&#8217;s stockholders, and have agreed to settle the Action upon the terms and subject to the conditions set forth in the Stipulation. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Each of the Individual Defendants denied and continues to deny that he or she has committed or attempted to commit any violations of law, any breaches of fiduciary duty, or any wrongdoing whatsoever, and expressly maintains that, at all relevant times, he or she acted in good faith and in a manner that he or she reasonably believed to be in the best interests of Cardinal Health and its stockholders.  Each of the Individual Defendants likewise denies all of the allegations made by Plaintiffs in the Action.  The Individual Defendants further deny that Plaintiffs, Cardinal Health, or Cardinal Health&#8217;s stockholders suffered any damage or were harmed as a result of any act, omission, or conduct by the Individual Defendants as alleged in the Action or otherwise.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cardinal Health believes that the Settlement is in the best interest of the Company, its stockholders, and its employees.  Defendants are, therefore, entering into this Settlement for the benefit of Cardinal Health to eliminate the uncertainty, distraction, disruption, burden, risk, and expense of further litigation.  Pursuant to the terms set forth below, the Stipulation (including the exhibits thereto) shall in no event be construed as, or deemed to be evidence of, an admission or concession by the Defendants with respect to any claim of fault, liability, wrongdoing, or damage or any defect in the defenses that Individual Defendants have, or could have, asserted.</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">What claims will the Settlement release&#63;</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the Settlement, the Parties agreed to give up certain rights called releases.  If the Court approves the Settlement, the Court will enter a Judgment dismissing the Action with prejudice pursuant to the terms of the Stipulation and the following releases will occur&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Release of Claims by Plaintiffs, the Company, and the Company&#8217;s stockholders&#58;  </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Without further action by anyone, upon the Effective Date,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Cardinal Health acting directly, Plaintiffs acting directly on behalf of themselves and derivatively on behalf of Cardinal Health, and any other Cardinal Health stockholder acting derivatively on behalf of Cardinal Health, and any of their respective legal representatives, heirs, executors, administrators, predecessors, successors, predecessors-in-interest, successors-in-interest and assigns, shall be deemed to have, and by operation of the Judgment, shall have, fully, finally, and forever released, relinquished, settled, discharged, and dismissed with prejudice every one of the Released Plaintiff Claims (including Unknown Claims) against the Released Defendant Persons, and shall be forever barred and enjoined from asserting, commencing, instituting, prosecuting, or continuing to prosecute any of the Released Plaintiff Claims against any of the Released Defendant Persons. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Release of Claims by Defendants&#58;  </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Without further action by anyone, upon the Effective Date, each of the Individual Defendants and Cardinal Health, and their respective legal representatives, heirs, executors, administrators, predecessors, successors, predecessors-in-interest, successors-in-interest and assigns, shall be deemed to have, and by operation of the Judgment, shall have, fully, finally, and forever released, relinquished, settled, discharged, and dismissed with prejudice every one of the Released Defendant Claims (including Unknown Claims) against the Released Plaintiffs, and shall be forever barred and enjoined from asserting any Released Defendant Claims against any of the Released Plaintiffs.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nothing in the Judgment shall in any way impair or restrict the rights of any Party to enforce the terms of the Stipulation, the Settlement, or the Judgment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">THE ABOVE DESCRIPTION OF THE PROPOSED RELEASES IS A SUMMARY.  </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The complete terms, including the definitions of the Effective Date, Released Plaintiff Claims, Released Defendant Persons, Unknown Claims, Released Defendant Claims, </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Effective Date of the Settlement is conditioned on the occurrence of each of the events described in Section 5.1 of the Stipulation, which include&#58;  (i) approval of the Settlement at or after the Settlement Hearing following notice to Current Company Stockholders as set forth in Section 3.2 of the Stipulation&#59; (ii) entry of the Judgment dismissing the Action with prejudice pursuant to the terms of the Stipulation and releasing the Released Defendant Persons and the Released Plaintiffs from the Released Claims&#59; and (iii) the passing of the date upon which the Judgment, including dismissal of the Action with prejudice pursuant to the terms of the Stipulation, becomes Final.  &#8220;Released Claims&#8221; means, collectively, the &#8220;Released Defendant Claims&#8221; and the &#8220;Released Plaintiff Claims.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Released Plaintiffs, and Released Persons, are set forth in the Stipulation, which is available on Cardinal Health&#8217;s investor relations website at ir.cardinalhealth.com and on Co-Lead Counsel&#8217;s websites at </font><font style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">www.gardylaw.com</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">www.ktmc.com</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">How will the attorneys be paid&#63;</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">After the Parties had agreed on all other material terms of the Settlement, the Parties separately negotiated in good faith to attempt to reach agreement concerning the amount of the Fee and Expense Award for Plaintiffs&#8217; Counsel.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cardinal Health has agreed that Plaintiffs&#8217; Counsel are entitled to receive 25% of the $124 million Settlement amount, subject to the approval of the Court, for their role in prosecuting and settling the Action.  Plaintiffs&#8217; Counsel have been working exclusively on a contingent fee basis, meaning that they would only be compensated for their time litigating the Action if they achieved a benefit for Cardinal Health through the Action.  The Court may award less than the requested amount and any change to the negotiated amount of the Fee and Expense Award will not otherwise affect the Finality of the Settlement.  The Court&#8217;s decision granting, in whole or in part, the application by Plaintiffs&#8217; Counsel for a Fee and Expense Award is not a condition of the Settlement or to entry of the Judgment.  The Parties acknowledge and agree that any Fee and Expense Award awarded by the Court in connection with the Settlement shall be paid by Defendants&#8217; D&#38;O Insurers to Plaintiffs&#8217; Counsel and shall reduce the net Settlement amount paid to Cardinal Health.  Cardinal Health stockholders are not personally liable for any such fees or expenses.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of Plaintiffs&#8217; Counsel&#8217;s application for the Fee and Expense Award, Plaintiffs will also submit an application to the Court requesting service awards of $2,500 to each individual Plaintiff for their time and effort in prosecuting the Action.  If approved, these service awards will be paid solely from the Fee and Expense Award.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">When and where will the Court decide whether to approve the Settlement&#63;</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Court will hold the Settlement Hearing at </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">2&#58;00 p.m. on October 4, 2022</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, at the Joseph P. Kinneary U.S. Courthouse, Room 167, 85 Marconi Boulevard, Columbus, Ohio 43215.  </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">In light of the ongoing Covid-19 pandemic, the Court reserves the right (in the Court&#8217;s discretion) to hold the Settlement Hearing by telephone or videoconference, and will provide notice of such decision by way of docket entry.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At the Settlement Hearing, the Court will consider whether the Judgment, substantially in the form of Exhibit B to the Stipulation, should be entered&#58;  (i) approving the terms and conditions of the Settlement as fair, reasonable, and adequate and in the best interests of Cardinal Health and its stockholders, (ii) dismissing the Action with prejudice pursuant to the terms of the Stipulation, (iii) ruling on the application by Plaintiffs&#8217; Counsel for the Fee and Expense Award, and (iv) ruling on Plaintiffs&#8217; application for service awards.  If there are objections, the Court will consider them.  At or after the Settlement Hearing, the Court will make decisions whether to approve these matters relating to the Settlement.  We do not know how long these decisions will take.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Please note that the date and time of the Settlement Hearing may change without further written notice</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">to Current Company Stockholders.  The Court further reserves the right to adjourn the Settlement Hearing, or any adjournment thereof, including the consideration of the application for the Fee and Expense Award and service awards, without further notice of any kind to Current Company Stockholders other than an announcement at the Settlement Hearing or at any adjournment of the Settlement Hearing.  The Court reserves the right to approve the Settlement, at or after the Settlement Hearing, with such modifications as the Parties may agree to without further notice to Current Company Stockholders.  The Court reserves its right to enter its Judgment approving the Settlement and dismissing with prejudice the claims asserted in the Action regardless of whether the Court has awarded the Fee and Expense Award and service awards.  The Court also reserves the right to extend any of the deadlines set forth in the Preliminary Approval Order without further notice to Current Company Stockholders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">How do I tell the Court if I don&#8217;t like the Settlement&#63;</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If you were a stockholder of Cardinal Health as of the close of trading on the date of the Stipulation (May 25, 2022) and you continue to own such stock through the date of the Settlement Hearing, you can object to the Settlement, including Plaintiffs&#8217; Counsel&#8217;s application for the Fee and Expense Award and service awards as described above.  You can give reasons why you think the Court should not approve the Settlement, the Fee and Expense Award, the service awards, or any part thereof.  The Court will consider your views.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To object, you must, no later than </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">twenty-one (21) calendar days prior to the date of the Settlement Hearing (by September 13, 2022)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, file with the Court a written statement of your objection.  Any such objection must also be received by the below-noted counsel by no later than </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">twenty-one (21) calendar days prior to the date of the Settlement Hearing (by September 13, 2022).  </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Your objection must clearly identify the case name and action number, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In re Cardinal Health, Inc. Derivative Litigation</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Case No. 2&#58;19-cv-2491, and must&#58;  (i) state the name, address, and telephone number of the objector&#59; (ii) be signed by the objector (or his, her, or its counsel)&#59;  (iii) state whether the objector is represented by counsel and, if so, the name, address, and telephone number of his, her, or its counsel&#59; (iv) contain a specific, written statement of the objection(s) and the specific reason(s) for the objection(s) or the reasons for the objector&#8217;s desiring to appear and be heard, including any legal and evidentiary support the objector wishes to bring to the Court&#8217;s attention&#59; (v) include documentation sufficient to prove that the objector owned shares of Cardinal Health common stock as of the close of trading on May 25, 2022 and continues to own such shares&#59; and (vi) state whether the objector and&#47;or his, her, or its counsel intends to appear at the Settlement Hearing and identify any witnesses the objector may call to testify and any exhibits the objector intends to introduce into evidence at the Settlement Hearing.  You do not need to hire an attorney.  If you choose to hire an attorney, it is at your expense.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To file with the Court, you must either have an electronic filing account with United States District Court for the Southern District of Ohio through PACER (Public Access to Court Electronic Records) to file electronically or mail or hand-deliver your papers such that they are received no later than </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">September 13, 2022</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> by the Office of the Clerk of the Court, United States District Court for the Southern District of Ohio, Eastern Division, Joseph P. Kinneary U.S. Courthouse, Room 121, 85 Marconi Boulevard, Columbus, Ohio 43215. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Hand-delivered filings can be made to any other location of the United States District Court for the Southern District of Ohio.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All objections must also be copied to the following attorneys&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Justin O. Reliford <br>Kessler Topaz Meltzer &#38; Check, LLP <br>280 King of Prussia Road <br>Radnor, PA 19087 <br>Email&#58; jreliford&#64;ktmc.com</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Jennifer Sarnelli <br>Gardy &#38; Notis, LLP <br>126 East 56th Street, 8th Floor <br>New York, NY 10022<br>Email&#58; jsarnelli&#64;gardylaw.com</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br></font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Robert W. Trafford<br>Porter Wright Morris &#38; Arthur LLP<br>41 South High Street <br>Suites 2800 - 3200 <br>Columbus, OH 43215<br>rtrafford&#64;porterwright.com<br></font><font style="font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br></font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">William Savitt<br>Wachtell, Lipton, Rosen &#38; Katz<br>51 West 52nd Street<br>New York, NY 10019<br>WDSavitt&#64;wlrk.com</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br></font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Albert G. Lin<br>Baker Hostetler<br>200 Civic Center Drive, Suite 1200<br>Columbus, OH 43215<br>alin&#64;bakerlaw.com</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If you do not make your objection in the manner provided herein, you waive your right to object to the approval of the Settlement, the Judgment to be entered approving the Settlement, the application for a Fee and Expense Award, and the application for service awards (including any right of appeal or collateral attack), and shall be forever barred and foreclosed from objecting to the fairness, reasonableness, or adequacy of the Settlement, the Judgment to be entered approving the Settlement, the Fee and Expense Award, or the service awards, or from otherwise being heard concerning these matters in this or any other proceeding, and you will be bound by the Judgment approving the Settlement, including the Releases.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Do I have to come to the Settlement Hearing&#63;</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No.  Plaintiffs&#8217; Counsel will answer questions the Court may have, but you and&#47;or your lawyer are welcome to come at your own expense.  If you submit an objection, you do not have to come to Court to talk about it.  As long as you filed and served your written objection with the proper documentation and in the manner described above and on time, the Court will consider it.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Unless the Court orders otherwise, any person who fails to object in the manner described above shall be deemed to have waived and forfeited any and all rights they may otherwise have to object to the Settlement and&#47;or Plaintiffs&#8217; Counsel&#8217;s application for the Fee and Expense Award and service awards (including any right of appeal) and shall be forever barred from raising such objection in the Action or any other action or proceeding.  Cardinal Health stockholders who do not object need not appear at the Settlement Hearing or take any other action to indicate their approval.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">How do I get more information&#63;</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Notice only summarizes the Settlement and is not a full description of the Action.  For more detailed information about the Action, you are referred to the papers on file in the Action, which may be inspected during regular business hours of each business day at the Office of the Clerk, Joseph P. Kinneary U.S. Courthouse, Room 121, 85 Marconi Boulevard, Columbus, OH 43215.  Copies of the Stipulation, the Amended Complaint, and other important case documents are also available on Co-Lead Counsel&#8217;s websites&#58; www.gardlylaw.com and www.ktmc.com.  You may also obtain more information by reviewing the Stipulation, which is also available on the Cardinal Health investor relations website at ir.cardinalhealth.com.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If you have questions regarding the Settlement, you may write or call Co-Lead Counsel&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Justin O. Reliford <br>Kessler Topaz Meltzer &#38; Check, LLP <br>280 King of Prussia Road<br>Radnor, PA 19087 <br>Telephone&#58; 610-667-7706 <br>Email&#58; jreliford&#64;ktmc.com</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Jennifer Sarnelli Gardy &#38; Notis, LLP <br>126 East 56th Street, 8th Floor <br>New York, NY 10022 <br>Telephone&#58; 212-905-0509 <br>Email&#58; jsarnelli&#64;gardylaw.com</font></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PLEASE DO </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">NOT</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> CALL OR WRITE THE COURT OR THE OFFICE OF THE CLERK WITH QUESTIONS REGARDING THIS NOTICE OR TO INQUIRE ABOUT THE SETTLEMENT.</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form and substance approved by Court Order Dated July 18, 2022.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>exhibit993-8xk.htm
<DESCRIPTION>EX-99.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4af64d79d50c4dcea191b45afc631f8b_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 99.3</font></div></div><div><font><br></font></div><div><font><br></font></div><div><img alt="image.jpg" src="image.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:222px"></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;text-indent:6pt"><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Notice to Stockholders of Cardinal Health, Inc. of Proposed Settlement of Stockholder Derivative Action, Settlement Hearing, and Right to Appear</font></div><div style="text-align:center;text-indent:6pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">TO&#58;       ALL PERSONS AND ENTITIES THAT HELD CARDINAL HEALTH, INC. COMMON STOCK AS OF THE CLOSE OF TRADING ON MAY 25, 2022 AND THAT CONTINUE TO HOLD CARDINAL HEALTH COMMON STOCK AS OF THE CLOSE OF TRADING ON OCTOBER 4, 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PLEASE READ THIS SUMMARY NOTICE CAREFULLY AND IN ITS ENTIRETY.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">The Court authorized this Summary Notice. This Summary Notice relates to a proposed settlement (the &#8220;Settlement&#8221;) of a stockholder derivative action&#58;  </font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:108%">In re Cardinal Health, Inc. Derivative Litig.</font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">, Case No. 2&#58;19-cv-2491 (S.D. Ohio) (the &#8220;Action&#8221;).  If the Court approves the Settlement, you will be forever barred from contesting the fairness, adequacy, and reasonableness of the Settlement and from pursuing the Released Claims.</font></div><div style="text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">The terms and conditions of the Settlement are set out in a </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Stipulation and Agreement of Compromise, Settlement, and Release, dated May 25, 2022 (the &#8220;Stipulation&#8221;).  All capitalized terms used in this Summary Notice that are not otherwise defined herein have the meanings provided in the Stipulation and&#47;or Notice.</font></div><div style="text-align:justify;text-indent:22.5pt"><font><br></font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Subject to the terms and conditions of the Stipulation, the Settlement will provide Cardinal Health with a gross payment of $124 million, less any Fee and Expense Award awarded by the Court to Plaintiffs&#8217; Counsel.  A more detailed description of the Action and the Settlement are set forth in the Stipulation as well as the full Notice to Cardinal</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%"> Health, Inc. Stockholders of Proposed Settlement of Stockholder Derivative Action, Settlement Hearing, and Right to Appear (the &#8220;Notice&#8221;), both of which are publicly available for review on Cardinal Health&#8217;s investor relations website at ir.cardinalhealth.com.  </font></div><div style="text-align:justify;text-indent:22.5pt"><font><br></font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">The Court will hold a Settlement Hearing at </font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2 p.m. on October 4, 2022, </font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">either in person at </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">the Joseph P. Kinneary U.S. Courthouse, Room 167, 85 Marconi Boulevard, Columbus, Ohio 43215,</font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%"> or by telephone or video conference,</font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:108%"> </font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">to </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">consider whether the Judgment, substantially in the form of Exhibit B to the Stipulation, should be entered&#58;  (i) approving the terms and conditions of the Settlement as fair, reasonable, and adequate and in the best interests of Cardinal Health and its stockholders, (ii) dismissing the Action with prejudice pursuant to the terms of the Stipulation, (iii) ruling on the application by Plaintiffs&#8217; Counsel for the Fee and Expense Award, and (iv) ruling on Plaintiffs&#8217; application for service awards.  </font></div><div style="text-align:justify;text-indent:22.5pt"><font><br></font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:107%">If you owned Cardinal Health stock (NYSE&#58; CAH) as of the close of trading on May 25, 2022 and continue to hold Cardinal Health common stock as of the date of the Settlement Hearing, you may object to the Settlement, including </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Plaintiffs&#8217; Counsel&#8217;s application for the Fee and Expense Award and service awards and appear at the Settlement Hearing to show cause why the Settlement, Judgment, or the applications for a Fee and Expense Award and service awards should not be approved and entered.  Any such objections </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:107%;text-decoration:underline">must</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> be filed with the Court and served on counsel for the Parties </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:107%">no later than September 13, 2022</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> in accordance with the instructions set forth in the Notice</font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:107%">. </font></div><div style="text-align:justify;text-indent:22.5pt"><font><br></font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:108%">PLEASE NOTE&#58;</font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">  Because the Settlement involves the resolution of a stockholder derivative action, which was brought on behalf of and for the benefit of the Company, the benefits from the Settlement will go to Cardinal Health.  Individual Cardinal Health stockholders will not receive any direct payment from the Settlement.  Accordingly, there is no proof of claim form for stockholders to submit in connection with this Settlement.</font></div><div style="text-align:justify;text-indent:22.5pt"><font><br></font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:108%">Stockholders are not required to take any action in response to this Summary Notice.</font></div><div style="text-align:justify;text-indent:22.5pt"><font><br></font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Please visit the </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Investor Relations section of Cardinal Health&#8217;s website</font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%"> to read the full Notice and Stipulation for more information.  You may also email questions to Plaintiffs&#8217; Counsel&#58; Justin Reliford at </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">jreliford&#64;ktmc.com or Jennifer Sarnelli at jsarnelli&#64;gardylaw.com</font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">.  </font><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:108%">PLEASE DO NOT CONTACT THE COURT WITH QUESTIONS. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:22.5pt"><font><br></font></div><div style="text-align:right;text-indent:22.5pt"><font style="color:#231f20;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:108%">By Order of the Court</font></div><div style="text-align:right;text-indent:22.5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Contacts</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Media&#58; Erich Timmerman, </font><font style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">erich.timmerman&#64;cardinalhealth.com</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and (614) 757-8231</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Investors&#58; Kevin Moran, </font><font style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">kevin.moran&#64;cardinalhealth.com</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and (614) 757-7942.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cah-20220718.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:2eb8944f-de1f-415b-8bf2-41062c286f20,g:3e966e92-320a-412a-b21b-0469b6ff5c6d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cah="http://www.cardinal.com/20220718" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cardinal.com/20220718">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20220718_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20220718_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cardinal.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>cah-20220718_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:2eb8944f-de1f-415b-8bf2-41062c286f20,g:3e966e92-320a-412a-b21b-0469b6ff5c6d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_76f44950-32c4-42ef-9912-bfe5220acd4f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f53c99bb-632d-4d94-8f07-0ccbcc1e3bc1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_aaf51632-c95c-466f-a901-eb2a040631a2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_830d3e7c-056b-4d43-abe3-41757d0830cb_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_de9e4e19-d1e7-4bc2-95b7-6ff963c56130_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_0fa6a6ab-2e46-408c-842e-8a07b278565f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_9f30fb05-9b34-42c6-9731-5428c4522a35_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_83b13b74-fd74-4d8d-977e-3778bb180436_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6ba42e61-126a-434a-ad68-8aa33db76c47_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6b665e6e-cd2b-4fa8-b0ae-a1706acb197e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_66a8cde8-e1eb-4d9b-8ab4-9300c58ea4dc_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_1e37520c-eaa6-4df6-92b7-120e5339ac31_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_45edf892-ee49-4ab9-ac99-147041b89743_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a22cd84d-f807-4dbb-a1b8-d4320a03a8b2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_52e9c1b0-8dd2-43b9-93f8-525b73eea6a3_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_76eabaeb-147e-42b6-bb49-8aa316ae4076_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8c2e36cb-5d31-4d1e-bb19-3726549f9903_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_850e66e0-cfc2-4a79-883e-c022d6717ff8_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_44a86832-85be-45a6-98cb-7bcea68d512d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e485f8c1-8c61-4e93-9ebb-81c3b2d6776f_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_324f18fd-636e-4529-9dbb-f8844fe59349_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_db38428f-2dbf-4b00-829a-04b3dd0d3506_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_0f4431d7-22c0-405c-9cf9-9044f5f026ad_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>cah-20220718_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:2eb8944f-de1f-415b-8bf2-41062c286f20,g:3e966e92-320a-412a-b21b-0469b6ff5c6d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cardinal.com/role/CoverPage" xlink:type="simple" xlink:href="cah-20220718.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ba218ee5-e8da-4dee-bf86-d2f6d296fedd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_DocumentType_ba218ee5-e8da-4dee-bf86-d2f6d296fedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d9e1cb8e-33c0-456e-a92d-a825ebc7a140" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_DocumentPeriodEndDate_d9e1cb8e-33c0-456e-a92d-a825ebc7a140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8c8b77b7-6924-46ad-b86b-af1fafd39898" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_EntityRegistrantName_8c8b77b7-6924-46ad-b86b-af1fafd39898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ac7986de-fd3e-4afd-9c7f-5c554ec37da5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ac7986de-fd3e-4afd-9c7f-5c554ec37da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_fcff82bc-4e32-4a31-bb12-ed7acdd948a1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_EntityFileNumber_fcff82bc-4e32-4a31-bb12-ed7acdd948a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a3a7613a-9e1b-4030-acef-081d5a2033cf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_EntityTaxIdentificationNumber_a3a7613a-9e1b-4030-acef-081d5a2033cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0f9a9a47-ef15-489f-ad69-d165c9daa1a6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_EntityAddressAddressLine1_0f9a9a47-ef15-489f-ad69-d165c9daa1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ccadd3aa-f2e1-4fcc-9205-8ed66d8216f8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_EntityAddressCityOrTown_ccadd3aa-f2e1-4fcc-9205-8ed66d8216f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7f192067-e7db-492e-b3ef-bd8281de6cd8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_EntityAddressStateOrProvince_7f192067-e7db-492e-b3ef-bd8281de6cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c3c67135-4e1e-485d-94db-28e06bbf2baf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_EntityAddressPostalZipCode_c3c67135-4e1e-485d-94db-28e06bbf2baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_75330eec-6699-49ce-ad1a-d04358740161" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_CityAreaCode_75330eec-6699-49ce-ad1a-d04358740161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_233788d2-0dcf-4712-b0f8-c13c16b83dd9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_LocalPhoneNumber_233788d2-0dcf-4712-b0f8-c13c16b83dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_bea33c5d-335d-4776-b852-b917bc2b7d58" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_WrittenCommunications_bea33c5d-335d-4776-b852-b917bc2b7d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_3714b8ff-155e-45ce-a3e8-5dcbd027609a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_SolicitingMaterial_3714b8ff-155e-45ce-a3e8-5dcbd027609a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_6be18fc7-0b99-48eb-81d4-4506298e6205" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_PreCommencementTenderOffer_6be18fc7-0b99-48eb-81d4-4506298e6205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_75be7ecf-7654-4544-b57e-77a42ef6bc2c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_75be7ecf-7654-4544-b57e-77a42ef6bc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8de19355-6821-41e4-b595-aa14ffb5a28f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_Security12bTitle_8de19355-6821-41e4-b595-aa14ffb5a28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_11b60874-c530-4fec-99c0-f0438ed8ee4c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_TradingSymbol_11b60874-c530-4fec-99c0-f0438ed8ee4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7935ea69-638a-44d4-aed1-04dfb96c0fd2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_SecurityExchangeName_7935ea69-638a-44d4-aed1-04dfb96c0fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_63e51714-391a-46f0-a990-36350f382100" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_EntityEmergingGrowthCompany_63e51714-391a-46f0-a990-36350f382100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e869453a-9d0d-499a-8fbf-759a51c89822" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_EntityCentralIndexKey_e869453a-9d0d-499a-8fbf-759a51c89822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_03798aa0-39dc-4e00-99a5-cf5ae08bab2b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4ca6392c-c1af-477c-bee2-697582c32ff4" xlink:to="loc_dei_AmendmentFlag_03798aa0-39dc-4e00-99a5-cf5ae08bab2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image.jpg
<TEXT>
begin 644 image.jpg
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M$=_*!SD\CD$3:5L$LA#02)=?! 1Y" !1]>)J9H0E+?#CWGHK:AQ0'9'H"04
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=P&3LEBU;RO\!&&?IO]#71M0     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139743512425008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Apr. 02, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 18,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cardinal Health, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-0958666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Cardinal Place<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">43017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">757-5000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares (without par value)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CAH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000721371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>cah-20220718_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cah-20220718.xsd" xlink:type="simple"/>
    <context id="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2021-04-02</startDate>
            <endDate>2021-04-02</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl80L2ZyYWc6Y2JjNGIyNTQ1Y2VkNDNkZWJlM2YwNDdhYjI4MjdmNjQvdGFibGU6MzkwMjk1YmQ5YTQyNGEyOGFlMWQ5NzY3NzJlNjU5YTYvdGFibGVyYW5nZTozOTAyOTViZDlhNDI0YTI4YWUxZDk3Njc3MmU2NTlhNl8xLTEtMS0xLTE2NDc1Mw_724e7339-9a8c-4fa1-b8b7-470f1f6db7a3">0000721371</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl80L2ZyYWc6Y2JjNGIyNTQ1Y2VkNDNkZWJlM2YwNDdhYjI4MjdmNjQvdGFibGU6MzkwMjk1YmQ5YTQyNGEyOGFlMWQ5NzY3NzJlNjU5YTYvdGFibGVyYW5nZTozOTAyOTViZDlhNDI0YTI4YWUxZDk3Njc3MmU2NTlhNl8yLTEtMS0xLTE2NDc1Mw_2de731c4-51a9-4dbf-9698-f8d56a9dbac1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl83MDE_6f934b83-ccd9-40ab-a164-7511b31aea5f">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl8yMjQ_2f5650a3-1156-4fce-aecc-977500643713">2022-07-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTQ_1edd9a8f-6653-4f35-a2af-7d197331a393">Cardinal Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6N2Y5YjgxZjVjNjhhNDA4YWFlNTkxNDQxZDA5NWUwYzkvdGFibGVyYW5nZTo3ZjliODFmNWM2OGE0MDhhYWU1OTE0NDFkMDk1ZTBjOV8xLTAtMS0xLTE2NDc1Mw_87a3fcaf-91c8-4b48-840b-1be48262801b">OH</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6N2Y5YjgxZjVjNjhhNDA4YWFlNTkxNDQxZDA5NWUwYzkvdGFibGVyYW5nZTo3ZjliODFmNWM2OGE0MDhhYWU1OTE0NDFkMDk1ZTBjOV8xLTItMS0xLTE2NDc1Mw_7aa18916-0cb7-450a-bc21-2fe22671c987">1-11373</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6N2Y5YjgxZjVjNjhhNDA4YWFlNTkxNDQxZDA5NWUwYzkvdGFibGVyYW5nZTo3ZjliODFmNWM2OGE0MDhhYWU1OTE0NDFkMDk1ZTBjOV8xLTQtMS0xLTE2NDc1Mw_87c75855-8ca3-4a02-92e4-6dfc380e2a48">31-0958666</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTU_59b1c6a3-166e-4085-9eee-20a0e07fcbca">7000 Cardinal Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTY_34624e36-b182-4d31-84a2-d95b08e15b5d">Dublin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTc_0f25bfb1-3ffd-4657-93f8-0efe37cb3300">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTg_1aa4c4a2-b94c-4f2c-b825-2a01d1633846">43017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl82OTk_c12ccaac-aa22-4067-8066-dfda601b9a53">614</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGV4dHJlZ2lvbjphNGQzOTRjYzcwNjQ0ZTA5OWFlZGI2ZjY2MDg1ZmZjMl83MDA_374e0738-74d0-45d9-abe6-a0ef9af9f1b3">757-5000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6ZThjMzNhMGQ5NjQxNDRjYzk5NjM1MTMyZmNiNzdjNDcvdGFibGVyYW5nZTplOGMzM2EwZDk2NDE0NGNjOTk2MzUxMzJmY2I3N2M0N18wLTAtMS0xLTE2NDc1Mw_8dc7c697-e306-4f8c-85ba-b20a9040995c">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NTdmOTFhMzVhMjk1NDBjMzk3YzAxMjIwMTQyMWRkMWUvdGFibGVyYW5nZTo1N2Y5MWEzNWEyOTU0MGMzOTdjMDEyMjAxNDIxZGQxZV8wLTAtMS0xLTE2NDc1Mw_d817823a-10d6-4640-9858-844acd8129d4">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NTY3ZWJlMjQzYmJlNDM3MjgwM2UwZGRlNDAyYzkxMDkvdGFibGVyYW5nZTo1NjdlYmUyNDNiYmU0MzcyODAzZTBkZGU0MDJjOTEwOV8wLTAtMS0xLTE2NDc1Mw_90499db8-c8a7-4f61-b04e-a4e53cfdd59c">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6ZGI2MmY3ZjFkNzQzNDExNmFhZWQ4ODU3Y2Y1MjQyY2YvdGFibGVyYW5nZTpkYjYyZjdmMWQ3NDM0MTE2YWFlZDg4NTdjZjUyNDJjZl8wLTAtMS0xLTE2NDc1Mw_d599e7b3-cc4d-4d56-a7c8-1a0736541114">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NzdlMDlhODVmNGZhNDUyMDgwMjZhNTYzMGU3YzZlNTYvdGFibGVyYW5nZTo3N2UwOWE4NWY0ZmE0NTIwODAyNmE1NjMwZTdjNmU1Nl8yLTAtMS0xLTE2NDc1Mw_eb1747b4-741b-41ec-a65a-0d08a2e9ddb8">Common shares (without par value)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NzdlMDlhODVmNGZhNDUyMDgwMjZhNTYzMGU3YzZlNTYvdGFibGVyYW5nZTo3N2UwOWE4NWY0ZmE0NTIwODAyNmE1NjMwZTdjNmU1Nl8yLTEtMS0xLTE2NDc1Mw_e0a74164-2d9d-4b14-8e34-6823ebc16960">CAH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NzdlMDlhODVmNGZhNDUyMDgwMjZhNTYzMGU3YzZlNTYvdGFibGVyYW5nZTo3N2UwOWE4NWY0ZmE0NTIwODAyNmE1NjMwZTdjNmU1Nl8yLTItMS0xLTE2NDc1Mw_664821a1-f5d5-4783-87d4-b08f0252eab6">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i91ce4f2993c248e6a1a056da25338264_D20210402-20210402"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1MjZhZGQxZjE4MTRmZDU5YTA1MzI3ODI0MTA3ZGRmL3NlYzo0NTI2YWRkMWYxODE0ZmQ1OWEwNTMyNzgyNDEwN2RkZl8xL2ZyYWc6YTRkMzk0Y2M3MDY0NGUwOTlhZWRiNmY2NjA4NWZmYzIvdGFibGU6NmM2NjRjZDU5ZGQ5NDllMmE3MzI0ZThiOWM1OTQyZjgvdGFibGVyYW5nZTo2YzY2NGNkNTlkZDk0OWUyYTczMjRlOGI5YzU5NDJmOF8xLTEtMS0xLTE2NDc1Mw_cfef0eef-0c2c-46ea-8826-dd9fc457a04e">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ 8H3V5)>*NQS     $P(
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MT>M,[Q\FCUI&Z]Q*N??P2K8<<XY_M/P!4$L#!!0    ( &*$]E0D'INBK0
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 8H3V5&'6_2KO    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M8H3V5)E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " !BA/94&>!@(C\$  !T$   &
M    @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M8H3V5)^@&_"Q @  X@P   T              ( !@PP  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " !BA/94EXJ[',     3 @  "P              @ %?
M#P  7W)E;',O+G)E;'-02P$"% ,4    " !BA/94&445]3<!   G @  #P
M            @ %($   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 8H3V
M5"0>FZ*M    ^ $  !H              ( !K!$  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ 8H3V5&60>9(9 0  SP,  !,
M         ( !D1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^
) @  VQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cah-20220718.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cah-20220718.htm">cah-20220718.htm</File>
    <File>cah-20220718.xsd</File>
    <File>cah-20220718_lab.xml</File>
    <File>cah-20220718_pre.xml</File>
    <File>exhibit991-8xk.htm</File>
    <File>exhibit992-8xk.htm</File>
    <File>exhibit993-8xk.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cah-20220718.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "cah-20220718.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cah-20220718_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cah-20220718_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cah-20220718.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cah",
   "nsuri": "http://www.cardinal.com/20220718",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220718.htm",
      "contextRef": "i91ce4f2993c248e6a1a056da25338264_D20210402-20210402",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.cardinal.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220718.htm",
      "contextRef": "i91ce4f2993c248e6a1a056da25338264_D20210402-20210402",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000721371-22-000049-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000721371-22-000049-xbrl.zip
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M^U9OGWWO>3&=PY]>-HSV_Q]02P,$%     @ 8H3V5.Z"T6)N @  > <  !
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M>\M72$O&"4E!HL,4D#"2@,D4F2U(D4*,I@C^<OD*:TZIY@A@!(79B020*)0
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M:]OYSUK&Z@USQV)6_S&^)?F[:UU>9OGE[V5Q5UV9L6Y$_C"E4IABG(8@1%0
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MDBIBTA- J8TFH _,0='Z^\ZN@.F&)'4BFS!Q#WGK00>9QR"-,GP?]1T0H/!
M\H=B+N&)I"L@&YFAH@G_!R)'R10&N.\@,.))XLY &5*R&HC(EQE*";QICJ(,
M'@FT@-)\!0$)%RGQ/XL #Q/Q-D6,YMI!?FU7#>_.81X>>6OA6,#]$R5G'^GQ
MB^D1[""@OW;G/JS.$"[N0I$IM3LU3 FI1*DT,!#>1+Y &!E$%S.C$J\".O.
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M[ ]%!>&<!L/@O2DUCR(:(7\.>66N78\]O<"V9K%O: OE!+8I#O N$<;1!!U
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M9#2\1C9%@#@^@E.).!U2R0Z!DABE8LIP/;IK":/6) M9X<WD95!X0QRRJ83
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MS4!LG?BCD2MIJ<^%Z2!AFLV5.7_%/KMCSHOFT0IR#>$#BSTF"DD47QZQ8 C
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MF3_,&::,SVY(9_A-"Z@CPHU]!99;(M[&:2;!X$Q(ML+Q.P9FYHEC<F6*DR1
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MXR#3&W@0<1HJS30:__OF/SU"N<7DCIU2Z!IY8:(E6F1TSY"C(7"\XAQG8.N
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MD</]<.R'-\?$<O[$$8:DOV]JY3W:Y1[MTI4QQ Y0@KBU\'0S%RA':B9V>/=
M,"W YW)1.81=K"Z#A$OKY2BD-JH-D"78 #F1+#"1W]%%X"TALZ*:8J:Q"1MT
MR%@0E1] X4*7%'"NF+P)M7/*@VDZC2(+E8E<P8&4W&Z6KUFL<)>N*#$E%&2?
M5?(N<VW!Y,ZD P8-'*PL)*4\EWJB(J<J\,<JZ&F!/I\24;(FCUF']!X\=ANE
M/NTC],/4AF-)ZTN:*I;B2!^:1U$;F[M\J6CV<<Z@7>>8UX3J A- %\0'VWFS
M0Y;Z7**!Y '\S<:;7UR,["D&J%93"^KLU!+@/=1<$4"]*.!O/@[,>#W/@)A9
MUX>=HL&\18%5:'/1FO@4;'_X(*QI/<V!&PJTRAAL6!1"'$4@1;EAF#HD=N"&
M\4!3OQ[NRC0'@Q@GTB]0(R#4N21DBI7R0F4<8))Q3-HC]L'3C0""1]RN1_3B
M6!VUAW2CS%3%3)+D*E9_!K<YG"!-;;BA'X%"$-8X#C/8$HU^@RKUKH<$Y/D<
M71O(&#D21 W>8\R^BKOPMJ(>SCJ=O75N0B.&&FX^W)62?,:.!$U)=C-NW!SF
M%2QLF.+,NJ9ANPWAFL%K\/U,9$&8CA!KQN_62]!O\\HPS^>$AH"E+O@./-][
MWSOM8<H6@AY2<2PSV*489L5=L.9S$.O\/(&*2V'!=;0WT54.(R]<O%B*";V<
MN)>#[?A#)2A:! LF*+Z3-BP!6CK[_;&W1U-R/JPV.9%Z&20G L6)P;.-S4\J
M_?(.I5!GT28=N&,'&_VG[*$E(VVP-.8" C!'3NV%:B3>QH@K@TG;S0O096Q*
M@]LE]F8==">()&HP!OH9JY>J.%?=[RX\53<REHD@-;HFO:!"$OPFQ[-%;EY*
M@T&_CV [EJ0OY5.->DTJ9Z9"->@&>Y*=) 0S%F<X\N!SZ+(:,CK:)H'X4*K'
M<Y)'Q:6AV*<XZ#5P]C!K:J2RH.#Y"--,#Z/UJ$96SV#6S.8LZ038#0IAT?(.
M*T9.L>SM"I@*=!;"#J50;$X>,S"!)]8I1U)ZB!$YC0)UPE%CQ'\4+C^>K7CN
M]!68ZWNHT;55]E9H](1J%$?T3=E10(5D79]2^8+"5ASZZ$ 9>472O4::%!*F
M+4(#7P 5&E;"PZ-;WR,B='YQK W#WG68,P;=U/W&X#&5)6(U' PK=2G32M:
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M2/HI^A- *::_M:T+0C\"U*6S%=%O42>LV5!S4+1C^0C=,+H>7AC-[7<3?8(
M"F$>MU6:"'6MLZ7#)>EE[#W7^1Y<I]YFG\EU0E7I,]D-[?_E/;J*2]1?_]&!
MW^] 3@=G>7AMWGLLR ,KYQB-P\IX.9$_AW$9&4-&A77:H1$RYP1;F.=87:GC
M+U9NMIX@UXE;CT/NYJQGK_?%SLNC_]T7>_NGNR<'QV<'1^_$T2N!-XY/CHZ/
M3O?WQ,G^X?[.Z?ZI.#@5.^+T_=NW.R=_]%;(<<]LVFVJ2KNF(<C#NH> QS5
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M7WQ _-C6($OL,G3MK/XV-;G'S=-LS]+BXGNQJ+NX8CLI;:#?>K ^&?;DI;R
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M[_U8SKKU89[,X9]Q.4E__7]02P,$%     @ 8H3V5*L\G%57"@  ;R\  !(
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MK:T5K>V\+=A_: OJ+"[6"[T'GIEU#K<'H.A36+IZ:\UD0KGEOC.!@.EKBXA
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M1S8JVT_1S4?Q9_\!4$L! A0#%     @ 8H3V5&EE+5:>%P  E)4  !
M         ( !     &-A:"TR,#(R,#<Q."YH=&U02P$"% ,4    " !BA/94
M[H+18FX"  !X!P  $               @ ',%P  8V%H+3(P,C(P-S$X+GAS
M9%!+ 0(4 Q0    ( &*$]E14 76D?0H  $E>   4              "  6@:
M  !C86@M,C R,C W,3A?;&%B+GAM;%!+ 0(4 Q0    ( &*$]E3!<SKYK08
M .<P   4              "  1<E  !C86@M,C R,C W,3A?<')E+GAM;%!+
M 0(4 Q0    ( &*$]E3$0W '@4D  (G8 0 2              "  ?8K  !E
M>&AI8FET.3DQ+3AX:RYH=&U02P$"% ,4    " !BA/94^9E_2-DF   =T@
M$@              @ &G=0  97AH:6)I=#DY,BTX>&LN:'1M4$L! A0#%
M  @ 8H3V5*L\G%57"@  ;R\  !(              ( !L)P  &5X:&EB:70Y
@.3,M.'AK+FAT;5!+!08     !P ' , !   WIP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
